GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report...

102
GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. P0004-03 ANNUAL ENVIRONMENTAL REPORT 2010 EPA Submittal Date: March 31 st 2011

Transcript of GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report...

Page 1: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GLAXOSMITHKLINE (CORK) LTD.

IPPC LICENCE REGISTER NO. P0004-03

ANNUAL ENVIRONMENTAL REPORT 2010

EPA Submittal Date: March 31st 2011

Page 2: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 1

Contents

EXECUTIVE SUMMARY 4 

1.  INTRODUCTION 5 1.1  Site Description 6 1.2  Main Products 6 1.3  Employment 8 

2.  ENVIRONMENTAL DATA SUMMARY INFORMATION 9 2.1  Emissions to Water: Storm Water (Ref. Points SW02 and SW03) 9 

2.1.1  Summary Information 9 

2.1.2  Trend Analysis 10 

2.1.3  Surface Water Diversions 11 

2.2  Emissions to Water: Treated Effluent (Ref. Point SW01) 12 

2.2.1  Summary Information 12 

2.2.2  Trend Analysis 12 

2.2.3  Treated Effluent Non-Compliances 14 

2.3  Wastewater from Incineration Activities (Ref. Point W1) 14 

2.3.1  Details of Non-Compliances 15 

2.4  Emissions to Atmosphere 18 

2.4.1  Details of Non-Compliance 20 

2.4.2  Trend Analysis 22 

2.4.3  Validation of Atmospheric Emission Monitoring Systems 23 

2.5  Waste Management 24 

2.5.1  Waste Generation and Fates 24 

2.5.2  Waste Minimisation Indices 28 

2.5.3  Rejected Consignments of Waste 30 

2.5.4  Waste Analysis 30 

2.5.5  Analysis of Aqueous Wastes for Incineration 31 

2.5.6  Total Waste Management (TWM) Programme 32 

2.5.7  Audits of Waste Management Facilities 33 

2.6  Noise 33 2.7  Resource Consumption and Energy Efficiency 35 

2.7.1  Resource Consumption 35 

Page 3: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 2

2.7.2  Energy Consumption 35 

2.7.3  Energy Audit 36 

2.7.4  Operational Excellence in Energy Management 37 

2.7.5  Key Energy Management Projects 37 

2.7.6  Water Usage and Efficiency 40 

2.7.7  Production Efficiency 42 

2.8  Control and Monitoring 45 

2.8.1  Compliance with Condition 6.1 and 6.2 45 

2.9  Agency Monitoring and Enforcement 45 

2.9.1  Aqueous Emissions Sampling and Analysis 45 

2.9.2  Atmospheric Emission Sampling and Analysis 49 

2.9.3  IPPC Licence Audit 49 

2.9.4  EPA Site Visits/Inspections 51 

2.10  Environmental Incidents 51 2.11  AER Returns Table 57 

3.  ENVIRONMENTAL MANAGEMENT OF THE ACTIVITY 58 3.1  Environmental Management System 58 3.2  Environmental Management Programme Report 2010 58 3.3  Environmental Management Programme 2011 58 

4.  POLLUTANT RELEASE AND TRANSFER REGISTER (PRTR) 59 4.1  PRTR Report 2010 59 4.2  PRTR Proposal for 2011 59 

5.  OTHER REPORTS 59 5.1  Underground Tank and Pipeline Inspection and Monitoring 59 

5.1.1  Process Sewer Pipelines 59 

5.1.2  Foul Sewer Pipelines 59 

5.1.3  Surface Water Pipeline System 60 

5.2  Bund Integrity Assessment 60 5.3  Groundwater Quality Monitoring Reports 60 

5.3.1  Summary of Monitoring conducted on the 30th June 2010 61 

5.3.2  Summary of Monitoring conducted on the 24th of November 2010 61 

5.4  Residuals Management Plan 64 

Page 4: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 3

5.5  Environmental Liability 64 5.6  Financial Provision 65 

5.6.1  Known Liabilities (RMP) 65 

5.6.2  Unknown Liabilities (ELRA) 65 

5.6.3  Statement of Measures 65 

APPENDIX A  

Site Environmental Policy  

APPENDIX B  

Hazardous Wastes Arising on Site in 2010  

APPENDIX C  

Non-Hazardous Wastes Arising on Site in 2010  

APPENDIX D  

Environmental Management Programme (EMP) 2011  

APPENDIX E  

Environmental Management Programme (EMP) Progress Report 2010  

APPENDIX F  

PRTR and AER Summary Data Tables for 2010  

Table of Figures Figure 1.1 General Production Schematic............................................................................................ 7 Figure 1.2 Environmental Staff Organisational Chart………………………………………………………8 Figure 2.1 Comparison of pH of Surface Water Discharge ex SW02 .............................................. 10 (2005 to 210) ................................................................................................................................... 10 Figure 2.2 Comparison of TOC level of Surface Water Discharge ex SW02 ..................................... 10 (2005 to 2010)......................................................................................................................................... Figure 2.3 Surface Water Diversions 2007 to 2010……………………………………………………… 11 Figure 2.4 Comparison of Mass Emissions to Estuary (SW01) 2005 to 2010 ................................... 13 Figure 2.5 Comparison of Mass Emissions to Estuary (SW01) 2005 to 2010 ................................... 13 Figure 2.6 Comparison of Mass Emissions to Atmosphere 2005 to 2010 ......................................... 22 Figure 2.7 Comparison of Mass Emissions to Atmosphere 2005 to 2010 ......................................... 22 Figure 2.8 Comparison of Mass Emissions to Atmosphere 2005 to 2010 ......................................... 23 Figure 2.9 Waste Generation 2005-2010 ........................................................................................... 24 Figure 2.10 Breakdown of Non-Hazardous Waste Streams in 2010................................................. 26 Figure 2.11 Breakdown of Hazardous Waste Fates 2010………………………………………………..27 Figure 2.12 Comparison of Waste Management Data 2005 to 2010 ................................................. 28 Figure 2.13 Comparison of Waste Management Indices 2005 to 2010. ............................................ 30 Figure 2.14 Solvent Usage Breakdown for GSK Cork 2010............................................................... 43 Figure 5.1 Historical Trend in Ammonium Concentrations ................................................................. 63 Figure 5.2 Historical Trend in Total Coliforms Concentrations ........................................................... 63

Page 5: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 4

EXECUTIVE SUMMARY In the past year, GlaxoSmithKline Cork continued to produce active pharmaceutical ingredient (API) to supply demand for it’s portfolio of products. This demand has not remained as consistent as the site would hope for. In 2010, the site manufacturing volumes reduced by 30% compared to 2009. The plant is typically operating at ~20% capacity.

Despite these challenging circumstances, the site continues to invest in site infrastructure, to ensure it is central to GSK’s production capability. The site’s flexibility in terms of operation and people is key to return the site to increased production output in the future.

During 2010, one new product was introduced to GSK Cork (Nelarabine) and it is hoped that more will follow to utilise the plant capacity available.

In 2010, GSK continued to demonstrate strong environmental compliance reporting with it’s IPPC licence. The Environmental Protection Agency visited the site on five occasions (four sampling visits and one audit). The EPA Audit conducted in March 2010 recorded no non-compliances and nine observations. These observations were duly actioned and closed out by GSK EHS.

In terms of reduced waste generation at source, early phase process development involves reducing solvent waste and optimising reaction efficiency. Solvent recovery continues to be carried out on-site with sizable investment being undertaken to recover methylcyclohexane (MCH) from Horizant over the coming years and the introduction of a small scale solvent recovery rig in 2012 to enable the development of solvent recovery for new products.

Despite the challenging business environment, GSK Cork remains committed to environmental compliance. In 2010, the site invested €3.5 million in environmental operational and monitoring expenditure. Capital investment in environmental management projects totaled over €1.8 million.

The past year has seen another remarkable performance in the site’s energy reduction initiative with a significant reduction in electricity usage in 2010 due to the Energy Reduction Programme activities on site. Mains water usage was also significantly reduced due to the elimination of underground mains water leaks. In line with the site’s Energy Policy, Certification to EN16001 is scheduled for 2011.

Page 6: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 5

1. INTRODUCTION Licensee: GlaxoSmithKline (Cork) Ltd.

Location of Activity: Currabinny, Carrigaline, Co. Cork.

Licence Register Number: P0004-03.

GlaxoSmithKline (GSK) Cork Ltd. is based in Currabinny, located on the banks of Lough Beg near to the mouth of Cork Harbour. The facility produces bulk active pharmaceuticals for clinical supplies and final products. Goods are exported to other GSK locations worldwide for formulation and distribution.

GSK was granted an Integrated Pollution Control (IPC) Licence Reg. No. 4 on the 6th of December 1994. Due to new developments on-site, GSK was subsequently granted a revised IPC Licence Reg. No. 473 on 20th August 1999. The entire licence numbering system was changed by the EPA in July 2006, and the register number was changed to P0004-02. An IPPC Licence Review Application was submitted to the Agency in September 2006; IPPC Licence Register No. P0004-03 was issued on 10th July 2007.

One of the requirements of the IPPC Licence (P0004-03) is to prepare an Annual Environmental Report for submission to the EPA by the 31st of March of the subsequent year. This report, in compliance with Condition 11.8 of the licence, details environmental performance at the site for the period January to December 2010. This report has been prepared in accordance with the following EPA AER/PRTR Guidance Documents:

• Principles of PRTR and AER Reporting of Annual Environmental Information (Guidance Doc. No. 1).

• The Step by Step Guide for AER / PRTR Reporting for EPA Licensed Facilities (Guidance Doc. No. 2)

• EPA’s Guidance Note for Annual Environmental Reports, 2000 (Guidance Doc. No. 3)

• The EPA AER Guidance Note Annex on AER PRTR Reporting V.1.1 (Guidance Doc. No. 4)

• The AER/PRTR Electronic Reporting Workbook and Website User Manual (Guidance Doc. No. 5)

• Procedure for Creating and Submitting Your Full PDF AER (Guidance Doc. No. 6)

Condition 2.2 of GSK’s IPPC Licence requires the licensee to establish and maintain an Environmental Management System (EMS). GSK has established the elements of an EMS as relevant to the conditions of the IPPC Licence - refer to Section 3 below.

An Environmental Policy has been prepared and is posted at several locations throughout the site including the site Security Building. A copy is included in Appendix A for reference.

Page 7: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 6

1.1 Site Description GSK is located at National Grid Reference E 1782 N 0628, near the village of Ringaskiddy. GSK occupies a 52 acre site in Currabinny, approximately 21 km from Cork city on the Currabinny road.

Features of interest or sensitive locations in the immediate vicinity include the lagoon inside the approach causeway to GSK. The surrounding marsh is home to many animals and birds, a high tide roost for waders and wildfowl and acts as an important staging post during the annual migration of many water species. GSK in conjunction with the Irish Wildbird Conservancy (IWC) play a significant role in maintaining this wildlife sanctuary.

The original plant was developed between 1973 and 1975. Since the plant began operations in 1975, increased production has led to a number of expansions and modifications of production and ancillary facilities. However, throughout these changes attention has been paid to ensuring that the plant and its operations have had minimal impact on the environment.

Pollution control equipment on-site includes: two high temperature incinerators (both incorporating a DeNOx unit); an emergency scrubber; one thermal oxidizer; a wastewater treatment plant (biotreatment/chemical treatment); and three solvent recovery plants.

The site comprises:

• 7 No. Production Buildings (Buildings 1, 2, 3, 5, 6, 7 and 8) • a Milling/Nanomilling Facility (Building 4), • a Research and Development Building, (Building 9) • 2 No. Warehouses (for raw materials, intermediates, finished goods and

maintenance supplies), • External material storage areas including tank farms (waste and raw

materials), • an Environmental Control Centre, • a Waste Management Facility (for solid wastes), • Service Utilities, • Laboratories, • an Engineering Building, • Office Buildings, • a Cafeteria and a Security Building.

1.2 Main Products The plant operates on a 24 hour day, 7 day week shift basis. 85 tonnes of product (active pharmaceutical ingredient) were produced during the reporting period 2010.  

The products are manufactured by organic synthesis using batch processing operations. Each product is generated through a series of intermediate stages with each stage comprising a number of unit operations. A typical production process is outlined in Figure 1.1.

Page 8: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 7

Figure 1.1 General Production Schematic

The main unit operations carried out on site include the above production operations, as well as solvent recovery, utilities generation and pollution abatement.

The main products produced during 2010 were:

• Lapatinib • Eltrombopag

• Horizant (Solzira) • Abacavir

• Ropinirole • Paroxetine

• Nelarabine • Dutasteride

Raw materials are subjected to various physical and chemical changes in order to produce the required chemical in the correct form. As a result, solid, liquid and gaseous emissions are generated. These emissions are subjected to physical and chemical treatment to remove any toxic, odorous or environmentally sensitive substances in accordance with IPPC Licence Reg. No. P0004-03 prior to discharge from the facility.

A large percentage of the non-recoverable solvents and certain aqueous solutions as well as gaseous emissions are treated/destroyed in the two incinerators on-site.

Section 2 below provides a summary of GSK’s monitoring data from the various pollution control installations for 2010 with respect to the following:

• Emissions to water

• Emissions to atmosphere

• Waste management

• Noise

• Resource consumption (energy, water) and energy efficiency

• Environmental incidents and complaints

A summary of EPA monitoring and enforcement is also provided.

Raw materials (reagents) and intermediates

Reactor vessel(suitable

temperature and pressure)

+ solvent Crystallisation

(under cold temperature)

Centrifuge/ Pressure Filter

Dryer Milling

(optional)

Product (bagging/drumming

for further processing)

Product crystals

Page 9: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 8

1.3 Employment There were 361 staff employed by GlaxoSmithKline at the end of 20101. The plant is a significant employer in the Ringaskiddy region. Figure 1.2 outlines GSK’s organisation for Environmental Management on-site.

Figure 1.2 Environmental Staff Organisational Chart

1 Excluding contract workers.

Site Director

EHS Team Leader

Environmental Regulatory Leader (ERL)

Environmental Operations Technical Leader (EOTL)

Environmental

Analytical

Chemist

Environmental

Engineer

6 x Shift Operators

(2 per shift)

1 Day Operator

Page 10: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 9

2. ENVIRONMENTAL DATA SUMMARY INFORMATION 2.1 Emissions to Water: Storm Water (Ref. Points SW02 and SW03)

The main point of discharge of surface water runoff from the site to the estuary is reference point SW02. A monitoring chamber is in place which allows for the continuous monitoring of pH and TOC prior to the discharge of surface water runoff at SW02 in accordance with Schedule C.2.3 of the IPPC Licence. Should the surface water pH exceed the limits of 6-9 or the TOC level exceed 200 mg/L, the monitor automatically shuts the valve on the line to the estuary and diverts the run-off to the retention ponds. From there it can be transferred across to the effluent treatment plant for treatment. A new firewater pond was added in 2007, which increased the retention capacity by 23%, to 984,000 gallons (4,473 m3).

Surface water discharged from SW02 is also inspected visually on a weekly basis for colouration and odour in accordance with Schedule C.2.3 of the IPPC Licence. There were no non-compliances related to surface water discharge from SW02 in 2010.

Surface water originating at Car Park A is discharged from point SW03. The discharge is inspected visually on a weekly basis for colouration and odour in accordance with Schedule C.2.3 of the IPPC Licence. There were no non-compliances related to surface water discharge from SW03 in 2010.

Note: SW04 as referenced in Schedule C.2.3 is a redundant, legacy surface water reference point, no longer applicable to the existing site drainage.

2.1.1 Summary Information For the purposes of this section, an average value for the pH and TOC results of the surface water discharge ex SW02 obtained over each month during 2010 is provided in Table 2.1.

Table 2.1: Emissions to Surface Water (SW02) in 2010; pH and TOC.

Month pH TOC (mg/L)

January 7.0  75.4 

February 6.9  52.7 

March 7.6  62.7 

April 7.7  40.0 

May 7.3  30.1 

June 7.2  39.2 

July 7.6  37.1 

August 7.5  85.6 

September 7.6  19.6 

October 7.7  27.0 

November 7.9  20.5 

December 8.2  19.6 

Page 11: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 10

2.1.2 Trend Analysis Figures 2.1 and 2.2 below show the trend analysis for the emissions to surface water 2006 to 2010.

6

6.5

7

7.5

8

8.5

Jan Feb Mar April May June July Aug Sept Oct Nov Dec

pH

Month

2005

2006

2007

2008

2009

2010

Figure 2.1 Comparison of pH of Surface Water Discharge ex SW02 (2005 to 2010)

0

20

40

60

80

100

120

Jan Feb Mar April May June July Aug Sept Oct Nov Dec

TOC

(mg/

L)

Month

2005

2006

2007

2008

2009

2010

Figure 2.2 Comparison of TOC level of Surface Water Discharge ex SW02 (2005 to 2010)

Page 12: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 11

2.1.3 Surface Water Diversions In 2007, the EPA requested that GSK report its diversions from surface water discharge to retention. The current arrangement, as explained in Section 2.1 above, is that surface water is continuously monitored for pH and TOC and non-compliant material is not discharged but directed to the surface water retention ponds and thence to the wastewater treatment plant for treatment. Hence non-compliant surface water is not discharged and there is no issue of non-compliance. There are two penstock valves operating in series that ensure that no discharge to the estuary occurs when surface water is rerouted for biotreatment.

In 2009, there were 120 diversions of surface water, a reduction of 44% from 2008 due to a series of measures implemented in 2008 to reduce the number of diversions to the surface water pond.

A target was set in the EMP for 2010 to reduce the frequency of diversions to the surface water retention ponds by 20% in 2010. The target for 2010 was achieved as there were 72 diversions of surface water, a further reduction of 40% from 2009. These figures are illustrated in Figure 2.3. This improvement was achieved by increasing awareness of the issue with all site teams in addition to reduced plant activity.

Figure 2.3 Surface Water Diversions 2007 to 2010

For the surface water effluent leaving the site, a target was set in the EMP 2010 that the TOC of the surface water from site be <30 mg/L in 2010, and to maintain awareness of surface water quality across the site. The target for 2010 was not achieved as the average TOC content of surface water discharged from the site at SW02 was 42.8mg/L. It is planned to reduce the TOC level to <38 mg/l (i.e. 10%) reduction in 2011.

Page 13: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 12

2.2 Emissions to Water: Treated Effluent (Ref. Point SW01) Process and foul effluents arising on site are treated in the on-site wastewater treatment plant. The treated effluent is then discharged into Lough Beg, Cork Harbour from reference point SW01. Two pump-outs are normally discharged each day, 30 minutes after each high tide. Effluent was pumped out on 343 days in 2010.

A daily 24-hr composite sample of the treated effluent is analysed for a variety of parameters. All parameters are monitored in accordance with the requirements of Condition 6 and Schedule C of the IPPC Licence. The sample is analysed for COD and suspended solids on a daily basis, weekly for BOD*, nitrates, total ammonium and phosphate. Organic solvents* are monitored on a quarterly basis, dioxins* on a bi-annual basis, and total heavy metals* and toxicity* on an annual basis. Note: * denotes that the parameter is analysed by an accredited external contractor.

2.2.1 Summary Information Table 2.2 below summarises the emissions to SW01 in 2010.

Table 2.2: Emissions of Treated Effluent (Ref. Point SW01)

Parameter 2009 2010 Max. Licensed Emission

% Compliance in 2010

Volume (m3/yr) 128,832 102,900 474,500 100

pH (average) 8.16 8.13 6-9 100

COD (kg/yr) 20,742

51,553 949,000 100

Suspended Solids (kg/yr) 2,396 2,480 118,625 99.7

BOD (kg/yr) 747 497 142,350 100

Nitrates (as N) (kg/yr) 140 130 7,118 100

Total Ammonium (as N) (kg/yr) 129 103 23,725 100

Phosphate (as P) (kg/yr) 611 395 7,118 100

Copper (kg/yr) 4.9 1.2 237 100

Zinc (kg/yr) 12.8 4.8 475 100

Toxicity (TU) <3.1 <3.1 10 100

TOC (kg/yr) 7,653 6,946 - -

Note that the mass emission of suspended solids of 2,480 kg in 2010 is equivalent to 2% of the total mass emission permitted under the licence. The issue of high total suspended solids arising in the incineration quench water (refer to Section 2.3.1) does not result in a high suspended solids content in the final effluent actually discharged from the site at SW01.

2.2.2 Trend Analysis Figures 2.4 and 2.5 illustrate the trend analysis for emissions of treated effluent to the estuary from SW01 for the years 2005 to 2010.

Page 14: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 13

0

10000

20000

30000

40000

50000

60000

70000

COD Suspended Solids TOC BOD

Mas

s Em

issi

ons

(Kg/

Yr)

Parameter

2005 2006 2007 2008 2009 2010

Licenced Mass Emission 949000 kg/yr

Licenced Mass Emission 118625 kg/yr

Licenced Mass Emission N/A

Licenced Mass Emission 142350 kg/yr

Figure 2.4 Comparison of Mass Emissions to Estuary (SW01) 2005 to 20102

0

200

400

600

800

1000

1200

1400

1600

1800

Nitrates (as N) Phosphate (as P) Total Ammonia (as N) Zinc Copper

Mas

s Em

issi

ons

(Kg/

Yr)

Parameter

2005 2006 2007 2008 2009 2010

Licenced Mass Emission 7117.5 kg/yr

Licenced Mass Emission 7117.5 kg/yr

Licenced Mass Emission 23725 kg/yr

Licenced Mass Emission 474.5 kg/yr

Licenced Mass Emission 237.25 kg/yr

Figure 2.5 Comparison of Mass Emissions to Estuary (SW01) 2005 to 2010

2 Note: 12 readings for TOC per annum versus daily for COD & SS and weekly for BOD.

Page 15: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 14

2.2.3 Treated Effluent Non-Compliances There was one non-compliance in emissions of treated effluent from SW01 with respect to Schedule B.2 of the licence during 2010.

Table 2.3 Non-compliances related to Emissions to Water: Treated Effluent (Ref. Point SW01) in 2010

Date Parameter

Limit

Non-Compliance

Root Cause CAPA CAPA Status

23rd April 2010

Schedule B2.

Suspended solids

250mg/l

381mg/l 1. Insufficient response to high level alarms by operators. 2. Forward flow pipelines were partially fouled – reducing flows.

A procedure was drafted to outline the management of flow rates in the WWTP. The SOP includes:

a. Response to LSH alarms

b. Monitoring of flow rates and response to be taken before alarm

c. Periodic preventative maintenance (jetting) of forward flow lines to prevent fouling

Confirm that LSH level is suitable.

Introduce an interlock between LSH on TK1805B with forward flow supply from P1802.

Change control overview screen to include LSH alarm to facilitate WWTP flow monitoring.

Closed 29th June 2010

2.3 Wastewater from Incineration Activities (Ref. Point W1) Incineration waste water is monitored at ref. point W1 and then combined with other treated effluent from the wastewater treatment plant prior to leaving the site as final effluent. Emissions at W1 are subject to Schedule B.2 of the IPPC Licence. The emissions are monitored for a selection for parameters as shown in Table 2.4 below. Monitoring for these parameters began in July 2007 with the issue of the current IPPC licence.

Page 16: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 15

Table 2.4 Monitoring of incineration wastewater at W1

Parameter Average Value in

2009 mg/L

Average Value in

2010 mg/L

Licensed Emission Limit Value

% Compliance

pH 7.55 - -

Flow rate 197.84 m3/d 136.32 m3/d 600 100

Total suspended

solids

25.83 26.11 45 mg/L for 100% of measurements, and 30 mg/L for 95% of

measurements

91

Hg 0 <0.00001 0.03 mg/L 100

Cd 0 <0.0001 0.05 mg/L 100

Tl 0.0004 0.00001 0.05 mg/L 100

As 0.00094 <0.00001 0.15 mg/L 100

Pb 0.00099 0.0002 0.2 mg/L 100

Cr 0.0595 0.0383 0.5 mg/L 100

Cu 0.0126 0.0029 0.5 mg/L 100

Ni 0.0482 0.0664 0.5 mg/L 100

Zn 0.0286 0.0282 1.5 mg/L 100

Dioxins/furans (TEQ)

0.0006 ng/L

0.0059 ng/L 0.3 ng/L 100

2.3.1 Details of Non-Compliances There were 30 non-compliances in 2010 with Schedule B.2 of the licence with respect to incineration waste water emissions at W1. These are detailed in Table 2.5 below. All relate to a high content of Total Suspended Solids (TSS).

During 2010, the main causes of TSS content were:

Water hardness (primarily CaCO3);

Swings in pH when burning Dichloromethane (DCM)

Shedding of inert incinerator firebrick as a consequence of normal operation (comprising principally insoluble aluminium oxide and silicon dioxide, with some iron oxide); and

Carbonaceous soot in quench water whereby steady state conditions arose in the incinerator firebox due to blockages in waste tanks

These non compliances give a result of 91.3% compliance with the IPPC Licence. Condition 4.5.1 of the licence requires 95% compliance with the emissions limit value of 30 mg/L for total suspended solids.

Page 17: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 16

Table 2.5 Non-compliances related to incineration quench water at W1 in 2010

Date Monitoring Frequency

Parameter Limit mg/l

Non-Compliance

mg/l

1 27/01/2010 Daily Sample TSS 45 119.5 2 28/01/2010 Daily Sample TSS 45 189 3 17/04/2010 Daily Sample TSS 45 221.1 4 18/04/2010 Daily Sample TSS 45 46.8 5 19/04/2010 Daily Sample TSS 45 301.5 6 20/04/2010 Daily Sample TSS 45 221.1 7 21/04/2010 Daily Sample TSS 45 403.2 8 22/04/2010 Daily Sample TSS 45 122.6 9 25/04/2010 Daily Sample TSS 45 221.1 10 26/04/2010 Daily Sample TSS 45 196.5 11 27/04/2010 Daily Sample TSS 45 47.5 12 19/08/2010 Daily Sample TSS 45 53.7 13 20/08/2010 Daily Sample TSS 45 50.2 14 22/08/2010 Daily Sample TSS 45 72.0 15 08/10/2010 Daily Sample TSS 45 71.8 16 09/10/2010 Daily Sample TSS 45 50.5 17 12/10/2010 Daily Sample TSS 45 52.0 18 13/10/2010 Daily Sample TSS 45 61.1 19 14/10/2010 Daily Sample TSS 45 70.3 20 15/10/2010 Daily Sample TSS 45 81.6 21 16/10/2010 Daily Sample TSS 45 90.3 22 17/10/2010 Daily Sample TSS 45 352.4 23 18/10/2010 Daily Sample TSS 45 182.3 24 19/10/2010 Daily Sample TSS 45 150.5 25 01/11/2010 Daily Sample TSS 45 67.2 26 06/11/2010 Daily Sample TSS 45 55.0 27 13/11/2010 Daily Sample TSS 45 52.9 28 14/11/2010 Daily Sample TSS 45 55.2 29 15/11/2010 Daily Sample TSS 45 66.0 30 16/11/2010 Daily Sample TSS 45 62.9 31

31/12/2010 High value of total suspended solids in quench

TSS 30 <95%

Page 18: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 17

Date Monitoring Frequency

Parameter Limit mg/l

Non-Compliance

mg/l

water from incinerator <95% annual compliance with IPPC limit 30mg/L

During 2008 and 2009 a number of items were progressed by GSK to reduce the TSS levels in this stream and these measures are summarised in the 2009 AER. GSK continued to progress these measures in 2010:

GSK have optimised the incinerator wastewater caustic control to reduce pH excursions that lead to water hardness solids precipitating. Air diffusers were installed in waste tanks to ensure improved mixing of wastes, reduced ‘layering’ of MDC and reduced HCl concentrations in the quench water.

Conclusions regarding TSS at W1

1. GSK acknowledges TSS above ELVs at W1 likely to occur due to water hardness and incineration firebrick shedding despite operational adjustments.

2. The contents of the firebrick will not cause an adverse impact on the aquatic environment;

3. GSK Cork will manage the suspended solids levels in the incineration quench waters to minimize as much as possible.

4. The incineration waste water joins with other waste water streams to form the final effluent from the site. The suspended solids in final effluent is typically at a level of ~10% of the ELV (250mg/L).

Page 19: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 18

2.4 Emissions to Atmosphere Monitoring and analysis of emissions to atmosphere is carried out in accordance with Conditions 4 and 5 and as specified in Schedule B.1 of the IPPC Licence. The main emissions to atmosphere from the site are from the emission points listed in Table 2.6 below. Note that the reference point naming/numbering convention was changed in the new IPPC Licence issued in 2007.

Monitoring of emissions to atmosphere was carried out during normal plant operating conditions. Quarterly sampling of hydrogen fluoride and hydrogen bromide from A2-1 and A2-3(A) is carried out over 30 minute sampling intervals. Annual sampling of particulates from API particulate vents is carried out over 2-hour sampling periods. An external contractor is commissioned to sample dioxins annually from A2-1 and A2-3(A).

Table 2.7 summarises the emissions to atmosphere during 2010. Note that the thermal oxidiser (ref. point A2-15) was not in use during 2010. The licence allows for a second thermal oxidizer (A2-16), which has never been installed. Incinerator No. 3A (A2-3A) was modified in 2010 to allow it to operate in thermal oxidizer mode, however due to plant process issues it was not operated in thermal oxidizer mode in 2010.

Particulate vents listed in Table 2.6 were sampled once during the year as required by Schedule B.1 of the IPPC Licence. All results (refer to Table 2.8) were found to be below the emission limit values of 1mg/m3 for total particulates and 0.15 mg/m3 for active pharmaceutical ingredients (API) respectively.

Bypass events

During periods where the incinerator is being bypassed, the emissions to atmosphere are vented via a scrubber (SCR1901) at the emission point (formerly termed Vent 3B). The total mass of VOCs emitted during bypasses in 2010 was 428Kg during 149hours 54min of bypass.

In fulfillment of Agency bypass requirements, while on bypass the solvent emissions are monitored by an online continuous monitor and processes will be controlled in order to ensure the relevant air quality limits are adhered to. A dispersion model uses the information from the online analyser and the predicted ground level concentration (GLC) is to be compared with GLC limits i.e. WHO, OEL/42 or Danish C.

An automated viewer is used for environmental operators to monitor solvent emissions during bypass events and will guide operations supervisors if emissions need to be controlled by process shutdown.

The agency is notified of each significant (>1hour) bypass event. Process operations are shutdown after 90 minutes in any event until incineration capability can be re-established. The agency will also be notified of any significant emission as follows:

>10% < 25% GLC Limits – Minor Incident (Rank of 1)

>25% < 50% GLC Limits – Limited Incident (Rank of 2)

>50% GLC Limits – Serious Incident (Rank of 3)

Page 20: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 19

The Agency is furnished with a quarterly summary of all bypass event details. While bypass capability is a key safety feature in incineration/thermal oxidizer operation, root causes of bypass events are addressed with a view to preventing reoccurrence & maximizing incineration uptime. CAPAs (Corrective Action & Preventative Actions) resulting from these investigations are managed on the site Environmental Incident tracker.

Table 2.6 Monitoring of Emissions to Atmosphere

Schedule B.2 Parameters Emission

Point

Emission point ref.

Continuous Quarterly Annual Incinerator 1 A2-1 TOC, total particulates,

CO, HCl, SOx, NOx (as NO2)

HF, HBr Dioxins (as TEQ), heavy metals

Incinerator 3A

A2-3A TOC, total particulates, CO, HCl, SOx, NOx (as

NO2)

HF, HBr Dioxins (as TEQ), heavy metals

Particulate vents

A2-10, A2-12, A2-13, A2-14, A2-112, A2-116,

A2-123, A2-124, A2-128, A2-126, A2-128, A2-146, A2-149, A2-150, A2-162, A2-163, A2-166, A2-301, A2-303, A2-308, A2-316,

A2-317, 2-318, A2-319, A2-320, A2-325, A2-328, A2-338, A2-339, A2-340, A2-341, A2-342, A2-343, A2-344, A2-345, A2-346, A2-347, A2-348, A2-351,

A2-352.

None None Pharmaceutical dust & total particulates

Page 21: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 20

Table 2.7 Mass Emissions to Atmosphere

Average concentration (2010) Parameter

(mg/m3 ) Emission point

A2-1

Emission point

A2-3A

Mass Emissions

(kg/yr) (2009)

Mass Emissions

(kg/yr) (2010)

% Compliance3

Particulates 0 0 0.6 0 100

SOx 6.7 1.54 43.75 89.08 100

NOx 29.59 74.08 2261.89 1581.24 100

CO 1.49 0.07 72.56 15.00 99.99

VOC, expressed as TOC

0.5 0.12 0.77 6.74 100

HCl 0.93 0.88 2.91 24.13 100

HF 0.0 0.03 2.23 0.56 100

HBr 0.22 0.47 9.13 10.33 100

Cd, Tl and their compounds

0.046 0.0016 0.201 0.453 100

Hg and its compounds

0.0 0 0.021 0 100

Other metals4 0.0 0 4.79 0 100

Dioxins/furans (as TEQ) (ng/m3 )

0.0008 0.0016 1.4997 E-06 3.5638 E-08 100

Flow rate Nm3/hr 3354 3354 - - -

Operating hours during 2010 (hrs)

2754 5264 - - -

2.4.1 Details of Non-Compliance During 2010, there were two non-compliances with the IPPC Licence relating to emissions to atmosphere, as detailed below in Table 2.8. The compliance rating for the year was > 99.99 %.

3 The IPPC Licence has ten-minute, dual half hour, and daily average limits that preclude calculation of one catch all annual limit for any measured parameter. % compliance of the monitoring results with the Licence Conditions is considered a more meaningful figure. 4 Other metals = Sb, As, Pb, Cr, Co, Cu, Mn, Ni, V and their compounds.

Page 22: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 21

Table 2.8 Non-compliances related to atmospheric emissions in 2010

Date Licence Condition

or Schedule

Period Emission Point Ref.

Parameter Limit Non-Compliance Root Cause CAPA CAPA Status

14th July 2010

Schedule B1

21.00-21.30

A2-1 30min Carbon monoxide

(CO)

100mg/m3 108.03mg/m3 Solids that have blocked line filters resulted in inconsistent waste flow & unsteady burning

Investigate methods of solids removal from waste tanks

Open, closure date due of 31July 2011

5th October

2010

Schedule B1

19.10-19.20

A2-1 10min Carbon monoxide

(CO)

150mg/m3 171.51mg/m3 Solids that have blocked line filters resulted in inconsistent waste flow & unsteady burning

1. Notify R&D to send very salty waste for off-site disposal.

2. Notify Operations to filter FDR decon liquors.

1. Closed

2. Closed

Page 23: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 22

2.4.2 Trend Analysis The mass emissions for emissions to atmosphere from A2-1 and A2-3A during 2010 are compared directly with the mass emissions for previous years in Figures 2.6 to 2.8 below. The general trend of decreasing mass emissions to atmosphere is related to a decrease in production levels at the site.

0.00

2,000.00

4,000.00

6,000.00

8,000.00

10,000.00

12,000.00

14,000.00

16,000.00

18,000.00

NOx

kg/y

r

2005

2006

2007

2008

2009

2010

Figure 2.6 Comparison of Mass Emissions to Atmosphere 2005 to 2010

0

100

200

300

400

500

600

700

800

900

1000

Particulates SOx CO VOCs as TOC

kg/y

r

2005

2006

2007

2008

2009

2010

Figure 2.7 Comparison of Mass Emissions to Atmosphere 2005 to 2010

Page 24: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 23

0

50

100

150

200

250

HCl HF HBr

kg/y

r

Parameter

2005

2006

2007

2008

2009

2010

Figure 2.8 Comparison of Mass Emissions to Atmosphere 2005 to 2010

2.4.3 Validation of Atmospheric Emission Monitoring Systems GSK has carried out the quality assurance testing in line with the European Air Emissions Standard IS EN 14181. The testing of the Automated Monitoring System (AMS) or Continuous Emissions Monitoring System (CEMS) is to test the validity of the monitoring data from incineration/thermal oxidiser monitors.

QAL2: Quality Assurance Level 2 (QAL2) testing has been completed and the results are compliant with the regulation requirements. A report was submitted to the Agency in 2009.

AST: An AST (Annual Surveillance Testing) was carried out in 2010 as required by IS EN 14181. The testing indicated (after retest on SO2 and TOC on Incinerator No.1) that the calibration functions at QAL2 are still valid. These findings were shared with the Agency during the course of 2010.

The program for testing over the coming years is as follows:

Year 2010 2011 2012 2013 2014

Test AST QAL2 AST AST QAL2

QAL3: Procedures are now in place to indicate the manner in which regular monthly calibrations occur and the quality assurance systems that are in place to support the testing.

Page 25: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 24

Calibration control charts are in place to ensure that the monitors’ performance does not drift out of control. These are reviewed regularly after each calibration.

During Q4 2010, it was noted that two of the continuous monitors (MCS – Infra red based) monitors were not performing adequately and were replaced/upgraded. This upgrade work means that QAL2 validations are needed to generate new calibration functions. This work will be completed as incinerators become operational in 2011.

2.5 Waste Management

2.5.1 Waste Generation and Fates In accordance with the EPA’s Guidance Note for Annual Environmental Reports and Condition 11.9 of the IPPC Licence, a record of the types, quantities and fates of all hazardous waste streams arising on site in 2010 is included as Appendix B. A record of all non-hazardous waste streams generated onsite in 2010 is included as Appendix C. The main figures are also included in the electronic AER Returns Worksheet to be submitted to the EPA separately, a copy of which is included in Appendix F.

Figure 2.9 compares the quantities of hazardous and non-hazardous wastes generated onsite for the years 2005-2010. The decrease in amount of hazardous waste generated in 2010 from 2009 (hazardous waste is down ~1,500 T compared to 2009) is attributed to a 33% decrease in production levels at the site. The decrease in non-hazardous waste generated in 2010 from 2009 (non-hazardous waste is down ~ 800 T) is attributed to a decrease in construction activity and in particular with demolition projects compared to 2009. 88% of non hazardous waste generated was sent for recycling or recovery in 2010.

0

5000

10000

15000

20000

25000

30000

2005 2006 2007 2008 2009 2010

2470.52

5594.6927601.24

1217.45 2138.541364.72

25,101

20,154

21,070

12,042

8,067

6,590

Tonn

es

Non Haz Haz

Figure 2.9 Waste Generation 2005-2010

Page 26: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 25

Figures 2.10 and 2.11 illustrate the percentage breakdown of each waste stream generated on-site. For summary purposes, the hazardous waste streams are categorised into disposal/recovery routes.

Page 27: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 26

Dry Mixed Recyclables0.26%Fibre Kegs

0.00%

Compost waste0.03%

C&D Waste25.86%

Glass0.41%

Food waste0.14%

Timber5.26%

Cooking Oil0.05%

Cables2.40%

Paper and Cardboard5.52%

Steel17.58%

Mixed Waste for Landfill7.54%

WWTP sludge34.95%

Figure 2.10 Breakdown of Non-Hazardous Waste Streams in 2010

Page 28: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 27

D9, Physico‐chemical treatment 0.0%

D10, Incineration 56.4%

D13, Blending or mixing prior to disposal 0.6%

R2, Solvent recovery 18.8%

R4, Recovery of metals 0.6%

R1, Use as a fuel 23.5%

R8, Recovery of catalysts 0.2%

Figure 2.11 Breakdown of Hazardous Waste Fates 20105

5 Of the hazardous waste that is disposed of via D10 incineration, approximately 60% is disposed of via incineration with heat recovery.

Page 29: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 28

2.5.2 Waste Minimisation Indices Key annual waste management data for the period January to December 2010 is presented in Table 2.9 below: Table 2.9 Waste Management Data Required for Calculation of Indices

Period Jan-Dec 2010

Raw Materials Usage (tonnes)6 1,822

Waste Produced (tonnes) 7,955

Waste Recovered (tonnes) 4,030

Off-Site Recovery (tonnes) 1,824

On-Site Recovery (tonnes) 2,206

Note that the figure for on-site recovery includes solvent waste partially recovered on-site as steam (1,546 T in 2010).

Figure 2.12 illustrates the trend in the waste management data between 2005 and 2010. The general trend of decreasing waste loads is related to a decrease in production levels on site and further improvements in waste management as outlined in Section 2.5.6

0.00

5,000.00

10,000.00

15,000.00

20,000.00

25,000.00

30,000.00

Qua

ntity

(T)

Raw MaterialsUsage

Waste Produced Waste Recovered Off-site Recovery On-site Recovery

2005 2006 2007 2008 2009 2010

Figure 2.12 Comparison of Waste Management Data 2005 to 2010

6 Includes solvent.

Page 30: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 29

The following indices have been calculated for the period January to December 2010:

Gross Waste Minimisation Index (Gross WaMI)

= 100× MaterialsRaw

Produced Waste

= 10018227955

×

= 437

Nett of Process Waste Minimisation Index (Nett of Process WaMI)

= 100× MaterialsRaw

Site-On Recovered Amount - Produced Waste

= 1001822

22067955×

= 316

Nett of Site Waste Minimisation Index (Nett of Site WaMI)

=

100×MaterialsRaw

Site-Off Recovered Amount -Site-On Recovered Amount - Produced Waste

= 1001822

182422067955×

−−

= 215

Page 31: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 30

Figure 2.13 illustrates the trend in the waste management indices between 2005 and 2010:

Figure 2.13 Comparison of Waste Management Indices 2005 to 2010

0

50

100

150

200

250

300

350

400

450

500

2005 2006 2007 2008 2009 2010

Year

Gross WaMI Nett of Process WaMI Nett of Site WaMI

Figure 2.13 Comparison of Waste Management Indices 2005 to 2010.

2.5.3 Rejected Consignments of Waste There were no rejected consignments of waste reported in 2010.

2.5.4 Waste Analysis 477 tonnes of dewatered WWTP sludge was collected and removed off-site during 2010. Table 2.10 summarises the quarterly and annual monitoring results for dewatered sludge as required by Schedule C.4 of the IPPC Licence. Heavy metals, organic matter and water content are analysed on a quarterly basis and organic compounds annually by an accredited external contract laboratory.

Page 32: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 31

Table 2.10 Dewatered WWTP Sludge Analysis 2010

Parameter Mar/10 May/10 July/10 Nov/10 Annual

Sludge solids (%w/w) 15.37 15.01 16.1 15.7 -

Organic Matter (%w/w)7 98.28 98.71 98.61 97.93 -

Water Content (%w/w)8 84.63 85.0 83.9 84.3 -

Cadmium (µg/L) 0.3 0.657 0.41 0.65 -

Chromium (µg/L) 4.31 91.5 44.1 87.8 -

Copper (µg/L) 9.03 158 84.3 93.4 -

Lead (µg/L) 1.33 8.29 5.98 12.0 -

Mercury (µg/L) <0.12 <0.14 <0.14 <0.06 -

Nickel (µg/L) 6.60 34.5 17.6 30.3 -

Zinc (µg/L) 511 1700 1010 781 -

VOCs (mg/L) - - - - 0

Semi-VOCs (mg/L) - - - - 0

Alcohols (mg/L) - - - - 42.5

- Indicates that no analysis was carried out for that particular parameter.

2.5.5 Analysis of Aqueous Wastes for Incineration Aqueous waste for on-site incineration is stored in the tanks TK1327, TK1328, TK1354, TK1381 and TK1382. The contents of each tank are analysed on an annual basis for organic solvents, metals, calorific value and water content in accordance with Schedule C.4 of the IPPC Licence.

Where the contents of the tank contain immiscible liquids or layers, a sample from each layer is taken. Samples from the tanks were taken on 26th February 2010 and a summary of the results is presented in Table 2.11. No layering was observed in the contents of the five tanks on this occasion. The presence of a high water content in wastes sent for incineration onsite is the subject of a Waste Accountability project underway as part of the site’s Energy Management System, discussed in Appendix D of this report.

7 100% minus Residue on ignition. 8 100% minus Sludge solids content.

Page 33: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 32

Table 2.11 Analysis of Wastes for On-site Incineration 2010 Parameter Salty waste (TK1327,

1328, 1354) Non-salty waste (TK1381,

TK1382)

Date of sample 26/04/10 26/04/10

VOCs (g/L) 625 194

Metals (mg/L) 10 6.3

Calorific Value (KJ/Kg)

Not combustible Not combustible

% Water Content 36.59 80.2

% Halogenated solvent (average)

1.5 0.4

2.5.6 Total Waste Management (TWM) Programme Since March 2005, Indaver Ireland has managed the shipment of all waste (both hazardous and non-hazardous) leaving the site. This Total Waste Management (TWM) approach has led to a reduction in the volume of waste going for disposal. It is GSK’s intention to continue to reduce the amount of waste disposed of off-site to landfill and incineration abroad in 2011. A number of actions are being implemented on-site via the TWM system to further improve waste management and disposal methods. These include:

• Indascan

On October 20th 2010, the Indascan project went live on site. Indascan is an Indaver owned system, whereby receptacles of waste in the Waste Drum Park have a unique barcode, which when scanned are uploaded to a central database. The benefits of the system are that a Real Time Inventory of quantities and levels can be accessed at any time.

• Management of Construction Compound

Indaver took over the day to day running and management of the Construction Compound in September 2010. Significant cost savings were directed to GSK Cork in this venture of approx. €35,000.

• Dry Mixed Recycable Bin Press

TWM introduced a method for cost saving in February 2010 for dry mixed recycables. Dry mix was traditionally placed in 1,100Ltr wheelie bins and collected on a weekly basis with GSK paying for transport and pick up charges. TWM introduced a bin press which reduced the amount of collections and resulted in savings per year in the region of €3,000.

• Paint Tin Press

Installation of a paint tin press to assist in the packaging and disposal of paint tin cans also resulted in a cost saving for GSK.

Page 34: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 33

• GSK Operator Training

In 2009, GSK Operators were trained in waste baling and labeling of waste onsite, with respect to ADR and IMDG Regulations. Refresher training was conducted twice during 2010 on 120 operators.

• Murphy Package Container

Due to high volumes of waste, Murphy Containers were historically kept onsite on a permanent basis. As volumes of waste have decreased over the last year, the container was put on a “on-call basis” resulting in a saving to GSK of €18,000 per year.

• Green Landscape Waste

Previously on site, the green landscape waste that O’Doherty’s generated was directed to the landfill compactor. A dedicated skip for green landscape waste is now in place and when full is sent to Greenstar for composting. Proposal is to reduce landfill figure by ~10Mt total tonnage 2010 with an estimated savings of €2,070 p.a.

2.5.7 Audits of Waste Management Facilities

During 2010, waste management facilities and hauliers were audited on GSK’s behalf by Indaver Ireland as outlined in Table 2.12:

Table 2.12 Waste Management Facilities Audited in 2010 Audit conducted by

Facility Name

Location Facility Type Conclusion

Indaver Ireland

Eras Eco

W0211-01

Youghal Sludge dewatering/drying facility

Acceptable

Indaver Ireland

Rilta

W0192-03

Kildare Drum recycling facility Acceptable

Indaver Ireland

JP Ryan WCP-CK-09-0696-01

Cork Waste haulier Acceptable

2.6 Noise Condition 6.12 of the IPPC Licence requires that a noise survey of the site operations be carried out annually and a summary of the results be submitted as part of the AER.

An external consultant carried out a noise survey of the site on the 15th and 16th of November, 2010. The facility was in normal production during the periods of survey. Table 2.13 below outlines the results obtained.

Schedule B.3 of the IPPC Licence sets a daytime noise limit of 55 dB (A) and a night-time noise limit of 45 dB (A) at the nearest noise sensitive locations (LAeq 30 minutes). Measurements were taken at the same noise-sensitive locations as per previous noise surveys, i.e. locations N1 to N4 and N5, a residence located to the west of N1.

In summary, the noise levels recorded at noise sensitive locations during 2010 were well within the IPPC Licence limits of 55 dB (A) daytime and at night-

Page 35: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 34

time, four of the five monitoring positions were well within the permitted limit of 45 dB (A) LAeq.

At monitoring position N2 (adjacent to a residential dwelling on the beach to the north of GSK), the total ambient night-time noise was recorded at 47 dB(A) LAeq, marginally in excess of the permitted licence limit. However, some of the ambient noise at position N2 emanates from a neighboring industrial facility.

Based upon the assessor’s observations during the survey work, the ambient night-time noise had no clearly audible tonal component or impulsive component and no significant tonal or impulsive noise was audible at any noise sensitive location.

It is proposed to undertake a noise survey at N2 during a scheduled plant shut down in 2011 to monitor the noise levels at N2 in the absence of GSK operations and determine the noise contributions at this location from other sources.

Table 2.13 Specific noise levels determined at the survey locations during 2010.

Specific Noise Level dB(A) (Industrial component of noise)

Location Daytime (08:00-22:00hrs)(Limit: 55 dB(A))

Night-time (22:00-08:00hrs) (Limit: 45 dB(A))

dB(A) L90 dB(A) LAeq dB(A) L90 dB(A) LAeq

N1 38 51 35 37

N2 44 46 46 47

N3 37 50 36-38 39

N4 46 49 41 42

N5 43 45 30-35 32-48

There was one complaint in relation to noise during 2010. On the 14th September 2010, a Currabinny resident complained about an intermittent humming noise. Investigations were carried out by GSK security, the EHS department and operational staff. A noise consultant’s investigation report indicated no significant noise at the house of the complainant on several occasions when the complainant could hear noise. The complainant was informed of the findings.

Page 36: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 35

2.7 Resource Consumption and Energy Efficiency 2.7.1 Resource Consumption

There are two sources of energy predominantly used on site: electricity and natural gas. Energy and water usage for the site for the period January to December 2010 are given in Table 2.14.

Table 2.14 Resource Consumption 2010

Diesel*

(m3/yr)

Natural Gas9

(m3/yr)

Mains Water

(m3/yr)

Electricity

(MWh)

39.2 4,003,602 187,217 29,083

* Note: Figure for diesel includes transport and non-transport figures.

Table 2.15 below compares the resource consumption levels from 2006 to 2010. There was another significant reduction in Electricity usage due to the Energy Reduction Programme activities. Mains water usage also significantly reduced due to elimination of underground mains water leaks. The increase in gas usage was due to the low air temperatures at the start and end of 2010, and an increase in the amount of waste being sent for incineration (Ref. Section 2.7.5 and EMP Progress Report 2010 – Appendix E).

Table 2.15 Trend in Resource Consumption

2006 2007 2008 2009 2010

Diesel (m3/yr) 138.5 141 193 73.0 39.2

Mains Water (m3/yr) 461,829 455,298 331,344 236,812 187,217

Electricity (MWh) 52,491 55,664 46,799 33,473 29,083

Natural gas (m3/yr) 4,435,796 3,852,183 4,440,037 3,823,936 4,003,602

Product (1° intermediate) (kg)

725,480 687,540 297,000 126,000 84,690

2.7.2 Energy Consumption The site’s energy usage is broken down as follows in Table 2.16, in accordance with the EPA’s Guidance Note on Energy Efficiency Auditing.

9 It is assumed that 10.8 KWh ≡ 1 m3.

Page 37: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 36

Table 2.16 Site Energy Usage for the period 2006-2010.

Period: 2006 2007 2008 2009 2010

Energy Stream Units Annual Quantity

Annual Quantity

Annual Quantity

Annual Quantity

Electricity Consumed On site

kWh 52,491,056 52,663,589 46,798,865 33,473,265 29,083,320

Electricity Imported

kWh 52,491,056 52,663,589 46,798,865 33,473,265 29,083,320

Electricity Generated On site (CHP sites only)

kWh 0 0 0 0 0

Electricity Exported offsite (CHP sites only)

kWh 0 0 0 0 0

Natural Gas Total kWh (Gross CV)

47,906,597 41,603,578 47,952,396 40,894,704 42,816,125

Natural Gas for CHP

kWh (Gross CV)

0 0 0 0 0

Gasoil Litre 0 0 0 0 0

LPG Litre 0 0 0 0 0

Light Fuel Oil Litre 0 0 0 0 0

Medium Fuel Oil Litre 0 0 0 0 0

Heavy Fuel Oil Litre 0 0 0 0 0

Other – please specify: Diesel

Litre 138,456 141,000 193,000 73,000 39,200

2.7.3 Energy Audit Condition 7.1 of the IPPC licence requires GSK to audit the energy efficiency of the site.

In 2010, GSK Cork put a roadmap in place to prepare for a Stage One Audit to EN16001 by year end based on the findings of the 2009 gap analysis of site operations to the standard. This work included:

• Identification of the factors which drive significant energy consumption onsite

• Development of Energy Performance Indicators and an associated reporting mechanism

• The formulation of Standard Operating Procedures to ensure the efficient operation of significant energy users, such as Refrigeration and HVAC systems

Page 38: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 37

• Development of an internal audit schedule to ensure both the management system and the significant energy users are performing optimally

• Formation of an Energy Management Team who have been tasked with the ownership of the energy management programme across the site

Each of these activities is in line with the Site Energy Policy. The Stage One Audit was completed successfully in December 2010 and the Stage Two Certification Audit is scheduled for Q1 2011.

2.7.4 Operational Excellence in Energy Management A new approach was adopted in 2008 to the tracking and management of energy using the tools of Operational Excellence (“OE”). During 2010 Operational Excellence (OE) continued being used to improve the effectiveness of the Energy Reduction Programme at the site. In April, a review of the programme, facilitated by OE, was carried out. All of the main 2010 Energy Reduction projects were reviewed to ensure that targeted reduction would be achieved.

Performance Management was improved with OE’s assistance. Building Energy Owners were appointed in key areas, such as R&D Building, Contractor’s Compound and Environmental Area. These owners are responsible for monitoring energy usage in their area against defined targets. Non conformances are investigated, and additional energy reduction projects and initiatives are identified.

2.7.5 Key Energy Management Projects

1. Cooling Water Optimisation

Following a review of all the site’s cooling water systems, a project was identified which would deliver electricity savings by operating some of the main cooling water pumps on header pressure control. The system was modified in 2010 to allow this form of control, and the pumps no longer run a constant load but will ramp up or down in response to system pressure.

2. Incinerator No.3 Thermal Oxidiser Mode Operation

The project to modify Incinerator No.3 to allow it operate in Thermal Oxidiser (TO) mode was successfully completed. However, due to plant process issues it was not possible to run the incinerator in TO mode during 2010.

3. Waste Accountability Improvement Project

During 2010, a system was put in place to record actual water usage versus planned water usage for cleaning and validation activities.

4. Improved Utilisation of Site Metering Systems

Improvements were made to the electricity metering infrastructure to improve its robustness and the reliability of usage data.

Page 39: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 38

Additional nitrogen flow meters were also installed in key usage areas and work began on the upgrade of the site’s steam metering.

Table 2.17 summarises the implementation costs and associated benefits in terms of energy, money and CO2 emissions from the energy-saving recommendations made in the energy audits.

Page 40: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 39

Table 2.17: Energy Audit Recommendations 2010

Predicted Annual Energy Savings

Annual CO2

Emissions Saving

Recommendations – Key Energy Management

Projects

Investment Cost

Category10

Payback Period (Year)

(kWh) (€) (Tonne)

Target Completion

Date

Responsibility Comments

Cooling Water Optimisation

M 1 1,428,000 111,384 694 Completed in 2010

Capital and Projects Group

Cooling water pumps output based on system pressure

Nitrogen Optimisation

L 1 556,671 43,420 271 Phase 1 completed in

2010

Capital and Projects Group and

Operational Engineering

Additional meters has meant improvement in monitoring of

nitrogen usage

Monitoring and Analysis of Significant Electricity Users

L 0.5 472,226 36,834 230 Phase 1 completed in

2010

Energy & Utilities Champion

Building Energy Owners were appointed in key areas, such as

R&D Building, Contractor’s Compound and Environmental

Area.

10 Either no/low cost, medium cost, high cost. No/low cost: €0-50,000; Medium cost: €50,000-150,000; High cost: >€150,000.

Page 41: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 40

2.7.6 Water Usage and Efficiency Condition 7.2 of the site’s IPPC Licence requires that GSK identify opportunities for reduction in the quantity of water used on site wherever possible.

Trends of water usage are reviewed weekly as part of GSK’s Performance Management process. Excess usage is investigated to ensure that overall water use is minimised.

Leak testing and repair

During 2010, work continued on the identification and elimination of leaks on the underground firewater mains. The repair of these leaks resulted in a saving of 17,500 m3/year.

Table 2.18 summarises the implementation costs and associated benefits in terms of water and money from the water-saving recommendation made as a result of the site’s water audit.

Water Reuse Opportunities

In 2011, it is planned to investigate the potential reuse of bio plant effluent and/or surface water for low grade utilities input. Significant tank capacity will become available in the coming year, which may be used for water storage for feed to the incinerator quench make-up water.

Page 42: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 41

Table 2.18: Water Audit Recommendation

Predicted Annual Energy Savings

Annual CO2 Emissions

Saving

Recommendations Investment Cost

Category11

Payback Period (Year)

(kWh) (€) (Tonne)

Target Completion

Date

Responsibility Comments

Identify and eliminate water leakage

L 0.25 0 10,000 0 2011 Facilities Engineer

Continuation of 2010 Leak Elimination Programme

11 Either no/low cost, medium cost, high cost. No/low cost: €0-50,000; Medium cost: €50,000-150,000; High cost: >€150,000.

Page 43: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 42

2.7.7 Production Efficiency Condition 7.4 of the IPPC Licence requires the site to undertake an assessment of the efficiency of use of raw materials in all processes, having particular regard to the reduction in waste generated.

1. Reaction Mass Efficiency

The principal products manufactured at GSK Cork have been assessed for process efficiency during research & development. During transfer of each product from R&D to full scale production operations, process efficiency improvement measures are identified. These include solvent recovery viability, process telescoping etc. Table 2.19 shows the Mass Productivity. Mass productivity reflects the contribution of each raw material in producing one kg of product. Effectively, the higher the mass efficiency, the leaner the process.

Table 2.19 Mass Efficiency

Product Mass Productivity (%)

Lapatanib12 2.0

Abacavir 2.3

Ropinirole 0.6

Eltrombopag 1.1

Dutasteride 0.2

These figures are continually assessed by GSK Corporate with an objective of carrying out specific efficiency improvement projects in line with business plans. Process chemistry and solvent recovery improvements will improve process productivity.

2. Re-use of Recovered Solvents

All products currently made on site have been evaluated for solvent recovery opportunities. Toluene and IPA are currently recovered on-site at GSK Cork for reuse on-site. Tetrahydrofuran is recovered off-site for reuse on-site.

• Toluene is recovered from two stages of production. Recovered toluene can replace up to 100% of the toluene used in these stages of the production process. In 2010, 36.2MT of Toluene was recovered on-site. 104MT was used on plant; the difference being made up from additional Toluene recovered in 2009. This made up 70% of the demand for Toluene in the process from which it can be recovered. This 104MT of recovered toluene represents 40% of the total toluene usage on site in 2010. • Isopropanol (IPA) is recovered from and reused in a single stage of production (API). 270MT of IPA was recovered on-site in 2010. 343.5MT was reused on plant, the additional material having been recovered in 2009. This represents a 62% replacement of IPA requirements for the process.

12 Lapatanib stages 2, 3 & 4 currently manufactured at Cork.

Page 44: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 43

• Tetrahydrofuran is recovered off-site by a third party in the UK. The material is recovered from two stages of a process for reuse in three stages of the process. In 2010, 484MT of foul THF was collected and shipped to the UK. 354MT of recovered THF were returned to site for reuse on plant. Due to carry over of stock from 2009, a total of 385.8MT recovered THF was reused on site in 2010, replacing 87% of the total THF usage in the process with recovered material. .

Figure 2.14 Solvent Usage Breakdown for GSK Cork 2010

Page 45: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 44

3. Development Work on Solvent Reuse

All products on site are evaluated for potential solvent recovery opportunities.

• Methylcyclohexane recovery was planned to be introduced to site in 2010. The material was to be recovered from a single stage of production for reuse in that same stage. The material was to be recovered on site and would have had the potential to replace up to 62% of the Methylcyclohexane usage on site. Significant development work on this project was undertaken in 2009 and 2010 but due to a change in timelines for product introduction to site, the recovery was not implemented. The recovery will now be initiated and the reuse of the recovered solvent validated in 2012. • Other solvents identified as being suitable for recovery going forward are 2Methyl Tetrahydrofuran, Methanol, Methyl tert Butyl Ether, Toluene, Acetonitrile, Ethyl Acetate, Iso Octane and n-Butanol.

• A significant project is planned for development and design in 2011 and for initiation in 2012. This project will involve the construction of a small scale solvent recovery rig to enable the development, implementation and validation of solvent recovery for new products on a smaller scale at R&D and industrialization phases; with the intention of the recovery being transferred to one of the larger solvent recovery units on site when volumes are high enough. Solvent being assessed for this rig include Isopropanol, Methyl tert Butyl Ether, Acetonitrile, Tetrahydrofuran, 2-Methyl Tetrahydrofuran, Toluene and Dichloromethane.

Page 46: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 45

2.8 Control and Monitoring 2.8.1 Compliance with Condition 6.1 and 6.2

In house wastewater analysis is carried out by competent staff. Each analyst has undergone suitable training and has demonstrated competency prior to carrying out compliance testing.

Water testing procedures have been validated for accuracy, precision, suitability with test matrix, LOQ and linearity.

Validation protocols, reports and maintenance contracts are in accordance with the relevant international standard.

Regular calibrations are carried out where possible using laboratory standards. A third party proficiency scheme is also used as quality control. Any out of spec analysis from the 3rd party proficiency scheme is investigated in accordance with Procedure ENVP-025 and the findings documented.

Third party analysis is carried out by suitably accredited laboratories using internationally recognized standard methods.

2.9 Agency Monitoring and Enforcement 2.9.1 Aqueous Emissions Sampling and Analysis

The EPA took samples of emissions to water from the site on the following dates during 2010:

1. 09/02/10 Treated effluent to SW01 (Split sample).

2. 09/02/10 Incinerator Quench Liquor (Split sample).

3. 09/02/10 Treated effluent to SW01 – Grab sample for VOCs (sample not split).

4. 05/05/10 Treated Effluent to SW01 (Sample not split).

5. 05/05/10 Incinerator Quench Liquor (Sample not split).

6. 07/09/10 Treated effluent to SW01 (Split sample).

7. 07/09/10 Incinerator Quench Liquor (Split sample).

8. 07/09/10 Treated effluent to SW01 – Grab sample for VOCs (Sample not split).

9. 07/09/10 Surface Water (Sample not split).

10. 10/11/10 Treated Effluent to SW01 (Split Sample).

11. 10/11/10 Incinerator Quench Liquor (Split sample).

12. 10/11/10 Surface Water (No sample available).

Table 2.20 provides a comparison of the EPA monitoring results with GSK’s monitoring results for the split samples. The parallel testing shows comparable results in most cases.

GSK results for suspended solids were higher than those reported by the Agency but significantly lower than the IPPC emission limit value of 300 mg/l. It is likely that the main reason for the difference in suspended solids results

Page 47: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 46

between the Agency and GSK is solids settling in the sample prior to taking the split sample. Where GSK & EPA analysis carried out in parallel differ significantly (> Z score of 2.0), GSK will follow the onsite procedure ‘ENVP-025 Review of Out-Of-Compliance Environmental Monitoring’ in the same way as out of spec proficiency test results will be investigated.

As reported in Section 2.8, the site laboratory methods are carried out in accordance with International Standards and have been validated for the key performance characteristics; linearity, precision, uncertainty, LoQ, and suitability with the text matrix.

GSK’s Environmental Laboratory participates in a recognised laboratory proficiency testing scheme “Aqua Check” for which several parameters are tested throughout the year. This scheme enables GSK’s Environmental Chemists to continually monitor the accuracy of test methods within the laboratory.

Page 48: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 47

Table 2.20 Comparison of EPA and GSK Monitoring Results on Split Samples

Parameter Emission

Limit Value (ELV)

1.2 times ELV13

EPA 09/02/10 Quench Liquor

GSK 09/02/10 Quench Liquor

EPA 09/02/10

Final Effluent

GSK 09/02/10

Final Effluent

EPA 07/09/10 Quench Liquor

GSK 07/09/10 Quench Liquor

EPA 07/09/10

Final Effluent

GSK 07/09/10

Final Effluent

EPA 10/11/10 Quench Liquor

GSK 10/11/10 Quench Liquor

EPA 10/11/10

Final Effluent

GSK 10/11/10

Final Effluent

Sample ref. - - 300270 - 300268 - 302151 1036QL-02

302149 1036FHT-02

302690 1045QL-03

302689 1045FHT-03

Volume m3/d 1,300 1,560 269 - 548 312 88 - 391 - - 231 -

pH 6-9 N/A 7.91 - 7.91 7.8 7.97 - 8.25 8.1 7.42 - 8.10 8.31

COD mg/L 2,000 2,400 - - 137 160 - - 95 112 - - 425 360

Suspended Solids mg/L 250

30 QL14

300 <2.0 - 8.4 21.7 6.0 12.3 <2.0 19.2 7.2 18.5 4.0 13.0

BOD mg/L 300 350 - - 4.1 - - - 1.3 1.38 - - 2.0 -

Nitrates (as N) mg/L 15 18 - - <1.00 - - - 10.4 - - 1.5 -

Total Ammonium (as N) mg/L

50 60 - - 0.053 - - - 0.067 <1.0 - - 0.045 -

Copper mg/L 0.5

0.5 QL

0.6 <0.005 - <0.005 - <0.005 0.0023 0.010 0.0083 <0.005 - 0.006 -

Zinc mg/L 1

1.5 QL

1.2 <0.005 - 0.047 - 0.033 0.0239 0.050 0.04 0.026 - 0.056 -

Arsenic mg/l 0.15 QL 0.18 0.037 - - - <0.001 0.0009 - - <0.005 - - -

Cadmium mg/l 0.05 QL 0.06 <0.0001

- <0.0001

- <0.0001

<0.0001

0.0001 - <0.0010 - - -

Chromium mg/l 0.5 QL 0.6 0.024 - 0.015 - 0.140 0.0878 0.051 0.031 0.104 - - -

13 Ref. IPPC Licence P0004-03, Condition 4.4.3, Discrete Sampling: “For parameters other than pH and temperature, no grab sample value shall exceed 1.2 times the emission limit value.” Therefore, a value which exceeds the composite limit, but is less than the total error target of +20%, may be in conformance when measurement uncertainty is applied. Where a value exceeds the composite limit by more than +20%, this constitutes a non-conformance/non-compliance with the IPPC Licence Limit. 14 Where QL denotes the ELV associated with Quench Liquor prior to mixing with on-site treated effluent.

Page 49: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 48

Parameter Emission

Limit Value (ELV)

1.2 times ELV13

EPA 09/02/10 Quench Liquor

GSK 09/02/10 Quench Liquor

EPA 09/02/10

Final Effluent

GSK 09/02/10

Final Effluent

EPA 07/09/10 Quench Liquor

GSK 07/09/10 Quench Liquor

EPA 07/09/10

Final Effluent

GSK 07/09/10

Final Effluent

EPA 10/11/10 Quench Liquor

GSK 10/11/10 Quench Liquor

EPA 10/11/10

Final Effluent

GSK 10/11/10

Final Effluent

Nickel mg/l 0.5 QL 0.6 0.039 - 0.025 - 0.133 0.0308 0.122 - 0.194 - - -

Thallium mg/l 0.05 QL 0.06 <0.001 - - - <0.001 <0.0009

- - <0.001 - - -

Lead mg/l 0.2 QL 0.24 <0.001 - <0.001 - <0.001 0.0001 <0.001 0.00008

<0.005 - - -

VOCs µg/l - - - - 1.20 - - - <1.30 - - - - -

- Indicates that no analysis was carried out for that particular parameter.

Page 50: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 49

2.9.2 Atmospheric Emission Sampling and Analysis The EPA did not carry out any atmospheric emission sampling on-site during 2010.

2.9.3 IPPC Licence Audit The EPA carried out a scheduled audit at the GSK site on 15th March 2010. No non-compliances were recorded.

The auditors held an opening meeting to discuss the objectives and scope of the audit. GSK gave a presentation on the progress of the implementation of the Environmental Management Programme.

The Auditors then carried out a tour of the site, special attention was given to the wastewater treatment plant, operation of Incinerator A2-3A and associated continuous environmental monitoring system (CEMS), solvent recovery plant and waste management.

The auditors held a closing meeting at which they made comments and relayed observations as shown in Tables 2.21.

Table 2.21 EPA Audit Observations

Item EPA Observation / Corrective Action Required

Response/Action by GSK

1 Gas calibration cyclinders:

The licensee shall update the procedure currently in place for the calibration of the CEMS analysers, to include the following:

• A system for tracking calibration certificates associated with the gas calibration cyclinders

• The procedure for conversion of gas cyclinder concentrations in ppm to the analyzer requirement for concentrations in mg/m3 units.

• A calibration gas cert tracking system including reference to bottles has been developed and is in place and in use. (Complete)

• GSK commited to updating calibration procedures to include a system for converting ppm gas cylinder concentrations to mg/m3. (30th June 2010) (Complete)

2 QAL2 Linearity and Variability Testing

The licensee shall ensure that the next annual surveillance test includes parallel measurements between the SRM and the CEM which indicates the variability in the data sets. Such variability testing must be performed in accordance with the requirements of EN14181. All future QAL2 reports must report 15 parallel measurements between a SRM and the CEM.

Contrary to the observation, parallel measurements with SRM were carried out for all parameters in the QAL2 reports submitted to the agency earlier in 2010. Variability tests were subsequently carried out for NOx, which had appreciable emission levels. Emissions for each other parameter were at low level clusters and <95% confidence interval for that parameter. At low concentrations, calibration functions are of little value due to the variability that can be seen at these levels. For this reason, calibration functions were not calculated for these parameters using parallel testing results and linearity results were deemed more appropriate.

GSK included parallel measurements with SRM values for the next AST test. Future QAL2 reports will include 15 parallel

Page 51: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 50

Item EPA Observation / Corrective Action Required

Response/Action by GSK

measurements. (30th June 2010) (Complete)

3 External Calibration of CEMS Analysers:

The licensee shall ensure that certified calibration gases of a known concentration are utilized to conduct external calibrations of the O2 analyser on-site.

GSK will ensure that a specific concentration of oxygen is used when calibration the oxygen analyser in future. (30th June 2010)

(Complete)

4 Methane as Calibration Gas:

The licensee shall switch to using propane as the calibration gas upon exhaustion of the current methane cyclinder. The data correction system must then be reconfigured to take account of this change in calibration.

Methane will be replaced by 33ppm propane as TOC analyser calibration gas (30th June 2010)

(Complete)

5 Temperature Correction Factor for the Talas System:

The licensee shall clarify the calculation formula utilized for the correction of temperature on the TALAS system.

The temperature correction factor is as follows in the TALAS system:

Cnorm = C x T+273

Tref + 273

Where Cnorm = normalised concentration

C = measured concentration

Tref = 0 deg C

T = Measured temperature deg C

(Complete)

6 Dust Analyser Calibration / Service Report:

The licensee shall ensure that all Calibration / Service Reports includes calibration certificates.

GSK will ensure that all calibration reports include calibration certs in future. (Complete)

7 Dioxin, Hydrogen Fluoride and Hydrogen Bromide Analysis Reports:

The licensee shall:

• Clarify the laboratory utilized, its accreditation status, the standards to which the above parameters are analysed and the uncertainty of measurement for these analyses.

• Ensure the above detail is included in future analysis reports

GSK attached updated external testing house (Cronin Environmental) reports for HBR, HF and Dioxins in their written response to the EPA. The reports identify the lab standards and their associated result uncertainties and the relevant accreditations included.

(Complete)

8 Bunding:

Bund adjacent to the cold stores was full of water due to a leaking pipe overhead. The bund contained four drums of Act-Brom 7334, a corrosive agent utilized for dosing the cooling water on-site.

The licensee shall repair the pipe and ensure all bunds on-site are checked daily and emptied as appropriate.

The pipe has been repaired and the bund emptied. The bunds are routinely checked and emptied by a dedicated operator.

(Complete)

9 Training Procedure for the Performance of The training procedure can be amended as needs be to include corrective actions of site

Page 52: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 51

Item EPA Observation / Corrective Action Required

Response/Action by GSK

CEMS Calibrations:

The training procedure put in place for CEMS calibrations, as a result of an observation raised in the last Site Inspection Report Ref. No. sm03nod, is not a documented training procedure. The procedure does not detail the training process or a set criterion which can be used to verify competency in the carrying out of the duty.

The licensee shall reassess the above procedure and amend as appropriate to meet the corrective actions fully as detailed in observation No. 7 of the last Site Inspection Report Ref. No. sm03nod.

investigation report of December last. This will be complete by the end of June 2010.

2.9.4 EPA Site Visits/Inspections There were no EPA inspections carried out on site during 2010.

2.10 Environmental Incidents All reportable environmental incidents which occurred during the year, such as:

• Any emission which does not comply with the requirements of this licence

• Malfunctions or breakdown of control equipment or monitoring equipment

• Any release of environmental significance to atmosphere from any potential emission point including bypasses e.g. diversions of the Lean Gas Header (LGH) to the emergency scrubber (Incinerator Trips).

Note: During 2010, incineration/lean gas header uptime equated to 99.27% (One incinerator in operation only at any time in 2010).

• Any incident with the potential for environmental contamination of surface water or groundwater, or posing an environmental threat to air or land, or requiring an emergency response by the Local Authority

are included in Table 2.24. They are also discussed in more detail in each relevant section above.

A total of 50 incidents were recorded between January to December 2010, of which, 12 were incinerator trip incidents15; incidents reported are outlined in Table 2.24.

15 GSK agreed with the EPA during 2004, that going forward, an incinerator trip will be considered a reportable incident where the duration exceeds 60 minutes

Page 53: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 52

Table 2.24 Summary of Environmental Incidents 2010

Date Incident Cause Corrective Action 1 15/01/2010 Trip/Bypass

Duration 7hr 56min

Resin lost from the water softening units into boiler feedwater blocked strainers and prevented flow through pumps. This resulted in incinerator tripping.

Monitor flows in the condensate system

2 16/01/2010 Trip/Bypass Duration 1hr 10min

Dirt on the window of the flame detector of pilot burner prevented burner from restarting. Time taken to clean window was longer than 1hour. Therefore, incident is EPA reportable.

Clean detector window.

3 17/01/2010 Trip/Bypass Duration 3hr 3 min

Resin lost from the water softening units into boiler feedwater blocked strainers and prevented flow through pumps. This resulted in incinerator tripping.

Monitor flows in the condensate system

4 23/01/2010 Trip/Bypass

Duration 1hr 4min

Resin lost from the water softening units into boiler feedwater blocked strainers and prevented flow through pumps. This resulted in incinerator tripping.

Monitor flows in the condensate system

5 27/01/2010 TSS Incident, W1 119.5mg/L Vs IPPC limit 45mg/L

Incinerator wastewater sample tank agitator failed leading to a buildup of solids on the side of the tank leading to high solids in samples taken.

Repair sample tank agitator

6 28/01/2010 TSS Incident, W1 189mg/L Vs IPPC limit 45mg/L

As Incident No. 5 above Ensure sample tank agitator is subject to PM.

7 28/01/2010 Trip/Bypass

Duration 1d 16hr 41min

Incin No.3 condensate line condenser feedwater loop showed no flow due to hand operated drive being removed from a valve which was inadvertently closed.

Cooling water I/O valves & filters to Incin No.3 condensate condenser to be checked.

The Cooling Tower water condenser water supply loop to be pressure tested.

Environmental Operator checksheets to be used in future before Incinerator start-up to include checks that hand valves are in correct position before operation commences.

8 07/04/2010

Isolated manhole SW corner of B2

Underground drain modification system did not alert the Facilities engineer of the fact that a pipeline had been obstructed in the course of excavation work.

Engineering Change control covering all underground explorations/ modifications is to be changed to include a signoff by the Facilities Engineer

9 17/04/2010 TSS Incident, W1 221.1mg/L Vs IPPC limit 45mg/L

1. Insufficient response to high level alarms by operators.. 2. Forward flow pipelines were partially fouled – reducing flows.

10 18/04/2010 TSS Incident, W1 46.8mg/L Vs IPPC limit 45mg/L

As above

A procedure is to be drafted to outline the management of flow rates in the WWTP. This SOP is to include: a. Response to LSH alarms b. Monitoring of flow rates and response to be taken before alarm

Page 54: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 53

Date Incident Cause Corrective Action 11 19/04/2010 TSS Incident, W1 301.5mg/L

Vs IPPC limit 45mg/L

12 20/04/2010 TSS Incident, W1 221.1mg/L Vs IPPC limit 45mg/L

13 21/04/2010 TSS Incident, W1 403.2mg/L Vs IPPC limit 45mg/L

14 22/04/2010 TSS Incident, W1 122.6mg/L Vs IPPC limit 45mg/L

15 23/04/2010 TSS Incident, SW1 381mg/L Vs IPPC limit 250mg/L

16 25/04/2010 TSS Incident, W1 221.1mg/L Vs IPPC limit 45mg/L

17 26/04/2010 TSS Incident, W1 196.5mg/L Vs IPPC limit 45mg/L

18 27/04/2010 TSS Incident, W1 47.5mg/L Vs IPPC limit 45mg/L

As above

c. Periodic preventative maintenance (jetting) of forward flow lines to prevent fouling

Confirm that LSH level is suitable.

Introduce an interlock between LSH on TK1805B with forward flow supply from P1802.

Change control overview screen to include LSH alarm to facilitate WWTP flow monitoring.

19 23/05/2010 Trip/Bypass Duration 7hr 56min

Pressure switch on IN1951 wrongly failed safe. No CAPAs

20 30/05/2010 Trip/Bypass Duration 13hr 15min

Failure of temperature probe in Incin No.1 firebox. No CAPAs

21 19/06/2010 Trip/Bypass Duration 1hr 15 min

Fault in pilot burner ignition loop transformer caused circuit breaker to fail open.

Replace Transformer on the pilot burner ignition loop

22 28/06/2010 Trip/Bypass

Duration 2hr 48min

Fault in pilot burner ignition loop transformer caused circuit breaker to fail open.

As above

23 14/07/2010 CO 108.03mg/m3 Vs 30min ELV 100mg/m3

Inorganic solids blocked line filters to the incinerator, which resulted in CO levels increasing.

Replace Transformer on the pilot burner ignition loop

24 19/08/2010 TSS Incident, W1 53.7mg/L Vs IPPC limit 45mg/L

Incinerator No. 1 Start up. Residual solids purged from the system into quench.

No CAPAS attributed.

Page 55: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 54

Date Incident Cause Corrective Action 25 20/08/2010 TSS Incident, W1 50.2mg/L

Vs IPPC limit 45mg/L Incinerator No. 1 Start up. Residual solids purged from the system into quench.

No CAPAS attributed.

26 22/08/2010 TSS Incident, W1 72.0mg/L Vs IPPC limit 45mg/L

Incinerator No. 1 Start up. Residual solids purged from the system into quench.

No CAPAS attributed.

27 27/08/2010 Trip/Bypass

Duration 1hr 53 min

Essential maintenance need on vent valve. The incinerator was put on bypass for longer than was planned with negiligible impact on the environment

No CAPAS attributed.

28 14/09/2010 Noise Complaint Complainant in Currabinny - intermittent humming noise. Noise investigated by GSK security, EHS & Ops staff. Noise consultant investigation report indicated no significant noise at the house on several occasions when the complainant could hear noise.

29 05/10/2010 CO 171.51mg/m3 Vs 10min ELV 150mg/m3

Solids present in the waste tanks lead to unsteady burning, which results in reportable levels of CO in the stack and sooty solids in the quench.

Trend waste feed flow rate with CO emissions to see if a flow rate set point can be advised to Env Ops to check & clean filters. Notification to R&D to send high salt & neutralised streams to Indaver for off-site incineration. Notification to GMS to filter by GAF Filter dryer decon liquors before sending to waste tanks

30 08/10/2010 TSS Incident, W1 71.8mg/L Vs IPPC limit 45mg/L

31 09/10/2010 TSS Incident, W1 50.5mg/L Vs IPPC limit 45mg/L

32 12/10/2010 TSS Incident, W1 52.0mg/L Vs IPPC limit 45mg/L

33 13/10/2010 TSS Incident, W1 61.1mg/L Vs IPPC limit 45mg/L

34 14/10/2010 TSS Incident, W1 70.3mg/L Vs IPPC limit 45mg/L

As above

As above

Page 56: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 55

Date Incident Cause Corrective Action 35 15/10/2010 TSS Incident, W1 81.6mg/L

Vs IPPC limit 45mg/L Coarse caustic dosing control system. Tune the caustic dosing system

36 16/10/2010 TSS Incident, W1 90.3mg/L Vs IPPC limit 45mg/L

37 17/10/2010 TSS Incident, W1 352.4 mg/L Vs IPPC limit 45mg/L

38 18/10/2010 TSS Incident, W1 182.3 mg/L Vs IPPC limit 45mg/L

39 19/10/2010 TSS Incident, W1 150.5 mg/L Vs IPPC limit 45mg/L

40 01/11/2010 TSS Incident, W1 67.2mg/L Vs IPPC limit 45mg/L

41 06/11/2010 TSS Incident, W1 55.0mg/L Vs IPPC limit 45mg/L

As above

As above

42 13/11/2010 TSS Incident, W1 52.9mg/L Vs IPPC limit 45mg/L

1. Quench blockages freed by pH drop but this dislodged water hardness solids from the equipment train. 2. High quench conductivity & low quench pH resulted in high quench level caused an incinerator bypass. Failure of fan 1945B extended the trip duration

1. When pH drop is required to clear blockages, then liquors should be dumped to bioplant TK1802. 2. Caustic dosing tuning improvement is to be made permanent by including in the incinerator start up checklist. 3. Incineration troubleshooting guide is to be updated to include quench tank regular washes by pH drop to avoid solids build up. 4. Fix fan 1945B

43 14/11/2010 Trip/Bypass Duration 1hr 46min

44 14/11/2010 TSS Incident, W1 55.2mg/L Vs IPPC limit 45mg/L

45 15/11/2010 TSS Incident, W1 66mg/L Vs IPPC limit 45mg/L

As above

As above

Page 57: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 56

Date Incident Cause Corrective Action 46 16/11/2010 TSS Incident, W1 62.9mg/L

Vs IPPC limit 45mg/L As above As above

47 01/12/2010 Noise limit breach 47dBA Vs 45dBa at location N2

No root cause established to date Survey to be carried out during GSK & Hovione s/d. Further investigation by D Quirke

48 07/12/2010 Trip/Bypass Duration 1hr 46min

Inadvertant closure of a hand valve on the cooling water supply to the steam condenser on Incinerator No 3.

Monitor the position of the hand valve on the cooling water supply to HE1932

Put in place a high temperature alarm to request operator to check the position of the cooling water supply hand valve

49 16/12/2010 Odour complaint Residual Cimetidine solids were being removed from TK1802 in the bioplant. Cimetidine liquors have a very low odour threshold.

Solids removed and sent off-site for disposal.

50 Year end High value of total suspended solids in quench water from incinerator <95% annual compliance with IPPC limit 30mg/L

Solids mostly due to water hardness & also some shedding of incineration firebrick. See individual incidents above.

Water hardness is not an environmental contaminant. Acid washings are directed to WWTP rather than quench. Firebox brick repaired to minimise shedding in so far as possible.

Page 58: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 57

2.11 AER Returns Table The main summary data on environmental performance and emissions from site in 2010 is included in the AER Returns Form Tables which will be submitted separately to the EPA. These tables will incorporate the Pollutant Release and Transfer (PRTR) data for the site (see Section 4 below). A copy of the PRTR and AER Returns Data Table is included herein as Appendix F.

Page 59: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 58

3. ENVIRONMENTAL MANAGEMENT OF THE ACTIVITY 3.1 Environmental Management System

Condition 2.2 of GSK’s IPPC Licence requires the licensee to establish and maintain an Environmental Management System (EMS).

During the implementation phase of the Environmental Management System, all employees received training on general environmental awareness. Environmental awareness training is included as part of new employee induction. The Environmental Regulatory Leader delivers this training in conjunction with the Training Co-coordinator.

Physical site audits and audits of the EMS are carried out in accordance with an internal audit schedule.

Environmental Standard Operating Procedures have been developed and are incorporated into the EHS training programme. All environmental procedures are reviewed on an annual basis to ensure compliance with site practices, legislative and Corporate requirements and other regulatory bodies.

3.2 Environmental Management Programme Report 2010 In accordance with the IPPC Licence, an Environmental Management Programme (EMP) 2010 was submitted to the Agency in March 2010 as part of the AER 2009.

The Environmental Management Programme Report 2010, which details the progress made towards meeting the stated objectives and targets of the EMP 2010, is included in Appendix E.

3.3 Environmental Management Programme 2011 In accordance with Condition 2.3 of the IPPC Licence, an Environmental Management Programme 2011 (Objectives and Targets for 2011+) has been prepared and is included in Appendix D.

Page 60: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 59

4. POLLUTANT RELEASE AND TRANSFER REGISTER (PRTR) 4.1 PRTR Report 2009

In March 2010, GSK submitted to the EPA a list of substances to be tracked under the Pollutant Release and Transfer Register (PRTR) Regulations. GSK has completed a mass balance for these substances as listed in the electronic AER Returns Data Table, which will be submitted separately to the Agency. A copy of the PRTR and AER Returns Data Table is included herein as Appendix F.

4.2 PRTR Proposal for 2011 It is proposed to track and report the same pollutants in 2011 for the PRTR as were reported for the year 2010.

5. OTHER REPORTS 5.1 Underground Tank and Pipeline Inspection and Monitoring

Condition 6.8 of GSK’s IPPC Licence requires that all underground effluent and foul sewer pipes are tested at least once every three years. There are no underground tanks on site.

The next round of testing and inspection of underground process pipelines is due by the end of 2011. The complete foul sewer system was hydrostatically tested in 2009.

In 2010 the focus of inspection was on storm drain testing:

456m of pipework was tested, the length of pipework that passed the initial test corresponded to 28m. 171m of pipework was replaced, 43m of pipework patch repaired and 30m of pipework was relined.

19 manholes were tested and 2 of these manholes passed the initial test. A total of 9 manholes were repaired. All of the above testing was carried out to EN1610 standard at a total cost of €93k.

There was also a project initiated in 2010 to install new drains feeding the firewater retention ponds which included installing 150m of pipework, 150m of pipework passed the initial test. 8 manholes were constructed and 8 manholes passed the initial test. All above testing was carried out to EN1610 standard at a total cost of €273k.

5.1.1 Process Sewer Pipelines A CCTV survey of process sewer pipes at GSK was carried out by an external consultant on 21st July 2008 and details were reported in the 2008 AER. The next round of testing and inspection of underground process sewer pipelines is due by the end of 2011.

5.1.2 Foul Sewer Pipelines A complete hydrostatic testing of the foul system (manhole chambers, main lines and branches into buildings) was completed in 2009. A crane location survey was completed in 2009 and a drawing and flowchart detailing the permitted locations for mobile cranes is now followed when situating a crane anywhere on site. Details are provided in the 2009 AER.

Page 61: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 60

5.1.3 Surface Water Pipeline System A CCTV survey of surface water pipes at GSK was carried out by an external consultant on 11th June 2008. All faults found in the survey were rectified in 2009 and reported in the 2009 AER.

A front end study on the practicality of carrying out hydrostatic testing and subsequent repairs on the surface water pipeline system was initiated in Q1 2010. In 2010 the focus remained on storm drain testing. 456m of pipework was tested, 28m of pipework passed (initial test). 19 manholes were tested, 2 of which passed (initial test). 171m of pipework was replaced, 43m of pipework was patch repaired and 30m of pipework relined. 9 manholes were repaired. All above testing was carried out to EN1610 standard at a total cost of €93k.

There was also a project to install new drains feeding the firewater retention ponds which included - 150m length of pipework installed, 150m of pipework passed (initial test), 8 manholes were constructed, 8 manholes passed (initial test). All above testing was carried out to EN1610 standard at a total cost of €273k

5.2 Bund Integrity Assessment Condition 6.8 of GSK’s IPPC Licence requires that all bunding structures and containers are tested for integrity and water tightness at least once every three years. There are 159 bunded areas at the GSK facility, with various types of internal finish, 3 of which are redundant.

The site implemented a new schedule for bund integrity assessment in 2009 and this bund integrity testing schedule was subsequently forwarded to the Agency in 2009. The schedule includes visual inspection of all bunds on an annual basis. Approximately 12-13 bunds to be inspected visually per month. All bunds were scheduled to be hydrostatically tested during 2009/2010 and thereafter on a three-year basis, as required by Condition 6.8 of the IPPC Licence.

During 2009, 155 bunds were tested and the findings detailed in the 2009 AER. In 2010 a total of 23 bunds were repaired at a cost of €73k, Phase 2 of the repair project to repair all remaining bunds including undersizing issues is currently underway with an estimated completion date of April 2011, at a cost of €89k.

5.3 Groundwater Quality Monitoring Reports Schedule C.6 of the IPPC licence requires GSK to sample and analyse groundwater from thirteen groundwater wells (AGW-1 to AGW-13) for the following parameters on a biannual basis:

• Total ammonium

• Major anions

• Major cations

• Individual heavy metals

• Trace organics.

Additional bacteriological parameters were analysed in all 13 monitoring wells and one borehole (BH-104) to monitor bacteriological and ammonium contamination in the groundwater on site.

Page 62: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 61

Schedule D requires GSK to submit a summary of these results as part of the AER. The full groundwater monitoring reports are held on file and may be inspected upon request.

5.3.1 Summary of Monitoring conducted on the 30th June 2010 Groundwater sampling was undertaken by an external consultant on the 30th June 2010. 13 bedrock groundwater monitoring wells (AGW-1 to AGW-13) and one perched groundwater well (BH-104) on site were sampled. Additional bacteriological parameters were analysed in all monitoring wells to monitor bacteriological and ammonium contamination in the groundwater on-site.

Results of testing were compared against the EPA’s Interim Guideline Values (IGVs).

• The ammonium concentrations were elevated above the relevant standards in all monitoring wells with the exception of AGW6, AGW1, AGW 7 and AGW8. In recent years, leaking foul drains on-site were thought to be the main contributor. Historical monitoring has shown an overall decline in ammonium concentrations on-site. This decrease in concentration is attributed to a programme of drain inspection and repair works undertaken on–site by GSK since 2008.

• Total coliforms, which can be naturally occurring, were <1ct/100ml in all 14 samples. E.coli contamination which is indicative of relatively recent faecal waste remained at low concentrations on-site (<1ct/100ml in all 14 samples) compared to elevated concentrations detected in November 2008. This decrease in concentration is attributed to a programme of drain inspection and repair works undertaken on–site by GSK since 2008.

• Elevated EC readings are expected given there is a tidal influence on the site.

• Selected major anions and cations are elevated in relation to EPA IGVs. The presence of some elevated anions and cations is likely to be associated with seawater influence on the site. This is comparable with previous groundwater sampling rounds.

• There was no detection of mineral oil in June 2010 similar to previous monitoring rounds.

• Concentrations of heavy metals were well below the EPA IGV standards

• There was no detection of VOCs in any of the monitoring wells apart from low level Isopropylbenzene detected in AGW-3 at 4ug/l and 2-Chlorotoluene detected in AGW12 at 3ug/l.

• No SVOCs were detected above the laboratory detection limits which are similar to previous monitoring rounds.

The key contaminant detected on-site in June 2010 ie ammonium concentrations are being tackled by the ongoing drain repair works onsite as detailed in Section 5.1 above and the EMP 2011 (Appendix D).

5.3.2 Summary of Monitoring conducted on the 24th of November 2010 Groundwater sampling was undertaken by an external consultant on the 24th of November, 2010.

Page 63: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 62

All 14 monitoring wells (AGW-1 to AGW-13 & BH-104) on the GSK site were sampled as part of the site’s biannual IPPC Licence requirements.

Additional bacteriological parameters were analysed in all monitoring wells to monitor bacteriological and ammonium contamination in the groundwater on-site.

The ammonium concentrations were elevated above the relevant standards in all monitoring wells with the exception of AGW6, AGW8 and BH-104. Previous site investigations concluded that the ammonium is likely to be from an on-site source. Identified leaking foul drains on-site are thought to be the main contributor. Historical monitoring has shown an overall decline in ammonium concentrations on-site (reference Figure 5.1) which is most likely due to foul drain repairs work together with a decrease in personnel working on-site.

• Total coliforms were <1ct/100ml in all 14 samples. E.coli contamination remained at low concentrations on-site (<1ct/100ml in all 14 samples) compared to elevated concentrations detected in November 2008. This decrease in concentration is attributed to a programme of drain inspection and repair works undertaken on–site by GSK since over the past two years.

• Selected major anions and cations are elevated in relation to EPA IGVs. This is comparable with previous groundwater sampling rounds. Again, the presence of some elevated anions and cations is likely to be associated with seawater influence on the site.

• Mineral oil was detected in one ground water well at AGW7 at a concentration of 0.4 mg/l against the EPA IGV of 0.1 mg/l.

• Concentrations of heavy metals were well below the EPA IGV standards in all 14 samples.

• There was no detection of VOCs in any of the monitoring wells apart from low level m and p-xylene and Iso-Propylbenzene detected in both AGW10 and AGW11 at 1ug/l and 2-Chlorotoluene and 4-Chlorotoluene detected in AGW5 at 14 ug/l.

• No SVOCs were detected above the laboratory detection limits which are similar to previous monitoring rounds.

Overall the groundwater quality in November 2010 is consistent with historical trends in groundwater quality with significant improvements in bacteriological contamination as outlined in Figure 5.2. Elevated ammonium concentrations are likely to be related to historical eaking foul drains on-site. The extensive programme of drain repair works on-site completed in 2008/2009 has led to an improvement in groundwater quality as seen in recent monitoring rounds and as illustrated in Figures 5.1 and 5.2.

As expected, the bacteriological parameters have degraded more quickly than the ammonium and therefore the decreasing trend in the bacteriological parameters as shown in Figure 5.2 was more rapid. Further groundwater monitoring will continue to track these parameters.

Page 64: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 63

AGW-1

AGW-7

AGW-13

0

10

20

30

40

50

60

70

80

90

100

Jun-

05Se

p-05

Dec

-05

Mar

-06

Jun-

06Se

p-06

Dec

-06

Mar

-07

Jun-

07Se

p-07

Dec

-07

Mar

-08

Jun-

08Se

p-08

Dec

-08

Mar

-09

Jun-

09Se

p-09

Dec

-09

Mar

-10

Jun-

10Se

p-10

Well ID

Con

cent

rati

on (

mg/

l)AGW-1

AGW-2

AGW-3

AGW-4

AGW-5

AGW-6

AGW-7

AGW-8

AGW-9

AGW-10

AGW-11

AGW-12

AGW-13

BH-104

AGW-3 333mg/l

Figure 5.1: Historical Trend in Ammonium Concentrations

AGW-1

AGW-6

AGW-110

2000

4000

6000

8000

10000

12000

14000

16000

18000

No

v-06

Mar

-07

Jul-

07

No

v-07

Mar

-08

Jul-

08

No

v-08

Mar

-09

Jul-

09

No

v-09

Mar

-10

Jul-

10

No

v-10

Monitoring Well

Con

cent

rati

on c

t/10

0ml

AGW-1

AGW-2

AGW-3

AGW-4

AGW-5

AGW-6

AGW-7

AGW-8

AGW-9

AGW-10

AGW-11

AGW-12

AGW-13

BH-104

Figure 5.2: Historical Trend in Total Coliform Concentrations

Page 65: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 64

5.4 Residuals Management Plan The Residuals Management Plan (RMP) for the site was reviewed in 2010 and submitted to the Agency as part of the 2010 AER. Condition 10.2.2 requires that this RMP be reviewed annually. The RMP was reviewed by GSK Environmental, Health and Safety personnel in conjunction with the external consultants responsible for the original RMP in September 2010 and subsequently submitted to the EPA. The reviewed RMP document is summarized as follows:

The site is licensed under IPPC for two activity classes: 5.16.0, the use of a chemical or biological process for the production of basic pharmaceutical products, and 11.1.0, the recovery or disposal of waste in a facility, namely the recovery or disposal of waste at the GSK facility by incineration and thermal oxidation. This automatically places the facility within Risk Category 3, the highest risk class. The EPA Guidance on Environmental Liability Risk Assessment, Residuals Management Plans and Financial Provision prescribes the scope of the Residuals Management Plan for such a Category 3 site and how each element may be derived. As there are no anticipated long-term environmental liabilities associated with the site, no Restoration or Aftercare Plans are required and a Closure Plan is sufficient.

The scope of the plan addresses the key issues, which would occur in an orderly shutdown of all the site activities on a phased basis over an estimated time period of 3-6 months. The basis of the plan is to ensure that, upon completion of the plan, the facility would be in a suitable state for future industrial use and its condition would not pose a risk to public health and safety or the environment. GSK are satisfied that all soil contamination issues have been resolved and remediated.

Cost estimates were prepared for each element of the closure plan. The costs are primarily related to the cleaning, decontamination, and decommissioning of equipment and divestiture/disposal of obsolete equipment and wastes. Further costs will be incurred in the provision of staff and security during the implementation of the Closure Plan and the completion of an environmental due diligence audit. The total cost of implementation of the plan is estimated to be in the order of €4.15m.

GSK confirms that the company has more than adequate resources from operations to fund the Residuals Management Plan. In addition, the value of the 52 acre site itself as a fixed asset far outweighs any potential closure or remediation cost.

5.5 Environmental Liability An Environmental Liabilities Risk Assessment (ELRA) for the site was conducted in 2008 and submitted to the Agency, in accordance with Condition 12.2.2 of the IPPC Licence. The methodology followed that prescribed by the EPA’s Guidance on Environmental Liability Risk Assessment, Residuals Management Plans and Financial Provision. The site lies in Risk Category 3, the highest risk class; hence a detailed site-specific ELRA was conducted on all foreseen unplanned but possible and plausible events occurring during the operational phase of the facility.

All risks to surface water, groundwater, atmosphere, land and human health were examined. The ELRA identified no risks of massive or major severity. All risks lay within the range moderate-minor-trivial. For each risk, the probability

Page 66: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 65

of occurrence over a 30-yr period was rated. Each risk was rated by multiplication of severity by probability of occurrence.

The existing mitigatory measures in place were deemed adequate to manage the environmental risks satisfactorily.

The most likely scenario and probability for each risk was taken and a cost ascribed for remediation. The maximal cost determined for an unplanned environmental liability associated with the operational phase of the facility is €270,000 (including 20% contingency).

The ELRA will be reviewed as necessary to reflect any significant change on site, and in any case every three years, per Condition 12.2.2 of the IPPC Licence. The next review of the ELRA is required in 2011 at the latest.

5.6 Financial Provision GSK is required to make financial provision for the known environmental liabilities identified and costed in the RMP and the unknown environmental liabilities identified, rated and costed in the ELRA.

5.6.1 Known Liabilities (RMP) The total cost of known environmental liabilities identified by the RMP for implementation of the plan is estimated to be in the order of €4.15m (including 25% contingency on decommissioning costs).

GSK confirms that the company has more than adequate resources from operations to fund the Residuals Management Plan. In addition, the value of the 52 acre site itself as a fixed asset far outweighs any potential closure or remediation cost.

5.6.2 Unknown Liabilities (ELRA) The most likely scenario and probability for each risk was taken and a cost ascribed for remediation. The maximal cost determines for an unplanned environmental liability associated with the operational phase of the facility is €270,000 (including 20% contingency).

The company is insured against environmental accidents/incidents to a value of €250,000. GSK Cork has made financial provision in its accounts for the remediation of environmental pollution and the tackling of unknown environmental liabilities as they are identified. This is more than adequate to cover the envisaged €270,000 (including 20% contingency) required to remediate the most costly risk. Such self-insurance by financial accounting is a suitable financial instrument per Table 5.3 of the EPA’s Guidance Note.

In the case of an off-site event, there are sufficient financial/insurance provisions in place to return the environment to its original condition and pay any associated costs/expenses incurred by third parties or external services/agencies such as the EPA or Health and Safety Authority.

5.6.3 Statement of Measures

GSK is required by Condition 12.2.1 to provide an annual statement as to the measures taken or adopted at the site in relation to the prevention of environmental damage, and the financial provisions in place in relation to the underwriting of costs for remedial actions following anticipated events or accidents/incidents, as may be associated with the carrying on of the activity. The risk assessment exercise will include the accurate estimation of the

Page 67: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

Page 66

financial provisions required for the underwriting of such costs. The amount of indemnity held shall be reviewed and revised as necessary, but at least annually.

The expenditure on environmental control and measures to improve environmental protection in and around the site is shown in Table 5.2 below.

Table 5.2 Expenditure by GSK Cork in 2010 on Environmental Control

€ Capital expenditure on air management onsite 398,403

Operational expenditure on air management onsite 1,419,000 Capital expenditure on waste management onsite 34,910

Operational expenditure on waste management onsite 269,000 Operational expenditure on waste management offsite 654,410

Capital expenditure on water management onsite 1,026,640 Operational expenditure on water management onsite 1,088,000 Operational expenditure on water management offsite 130,000

Repairs to bunded structures 73,000 Surface water sewer repairs 93,000

New drains to firewater retention pond 273,000

Total expenditure on environmental control in 2010 5,459,363

Page 68: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

APPENDIX A

SITE ENVIRONMENTAL POLICY

Page 69: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

CORK ENVIRONMENTAL POLICY

GlaxoSmithKline has a world-wide commitment to conduct itself in a responsible manner to protect people and the environment and to ensure sustainable use of resources. Manufacturing and supporting facilities at the site are designed, constructed, operated and maintained in accordance with global, European and Irish legislation as well as GSK’s Environmental Standards. In addition to the above, SmithKline Beecham (Cork) Limited places a specific emphasis on the areas of operation listed below and consider them to be a vital part of our site operations: • A commitment to adhere to the GSK Environmental Policy and the associated Standards and

Guidance. • A commitment to operate at all times within the terms of the site Integrated Pollution

Prevention & Control (IPPC) Licence issued by the EPA. • A commitment to continuous improvement on environmental issues. • A commitment to prevent pollution by eliminating, or if that is not possible, reducing as far

as practicable all emissions to the environment. Reduction at source will be the first priority, followed by recycling and the use of end-of pipe technology only where reduction at source or recycling is not possible.

• A commitment to setting environmental objectives and targets on a regular basis. • A commitment to energy minimisation by incorporating energy efficient technologies in all

aspects of plant design and promoting energy awareness. • A commitment to liase openly on environmental issues with members of staff, the local

community and other interested parties. • A commitment to provide information on the environment to the public as per our

undertaking in the IPPC Licence. • A commitment to assess the environmental impact of all new projects in advance. • A commitment to raise environmental awareness at all levels within the Company. Review This policy will be reviewed annually through the Cork EHS Council. ___________________ May 2010 Finbar Whyte Vice President & Director, Cork

Page 70: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

APPENDIX B

HAZARDOUS WASTES ARISING ON SITE IN 2010

Page 71: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 Appendix B IPPC Licence Reg. No. P0004-03

Description of Waste EWC Code Tonnage Waste Haulier Waste Contractor/ Agent/Broker

Waste or IPC Permit or Licence

No.

Final destination Waste or IPPC Permit or Licence No.

Disposal or Recovery Code

Dilute hydrochloric acid 06 01 02 5.093 Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd. 36-2 AVG, Abfall-Verwertungs, Gesellschaft, Hamburg,Germany.

IB2234 D10

Nitric Acid 06 01 05 0.231 Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd. 36-2 AVG, Abfall-Verwertungs, Gesellschaft, Hamburg,Germany.

IB2234 D10

Acidic wastes 06 01 06 0.378 Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd. 36-2 AVG, Abfall-Verwertungs, Gesellschaft, Hamburg,Germany.

IB2234 D10

Calcium Hypochlorite Solution

06 02 05 2.253 Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd. 36-2 Indaver NV, Polderlietweg, B-2030, Antwerp, Belgium.

MLAVI / 9800000485 D10

Aqueous sludges 07 05 01 55.54 JP Ryan (CK WMC 34/01) Indaver Ireland Ltd. 36-2 AVG, Abfall-VerwertungsGesellschaft, Hamburg,

Germany.

IB2234 D10

Mixed solvent waste 07 05 01 43.448 Quay Transport Ltd. (CK WMC 139/03) / JP Ryan (CK WMC

139/03)

Indaver Ireland Ltd. 36-2 Indaver NV, Polderlietweg, B-2030, Antwerp, Belgium.

MLAVI / 9800000485 D10

Mixed solvent waste 07 05 03 223.841 Quay Transport Ltd. (CK WMC 139/03) / JP Ryan (CK WMC

139/03)

Indaver Ireland Ltd. 36-2 AVG, Abfall-Verwertungs, Gesellschaft, Hamburg,Germany.

IB2234 D10

Waste solvent 07 05 04 4.544 Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd. 36-2 AVG, Abfall-Verwertungs, Gesellschaft, Hamburg,Germany.

IB2234 D10

Waste solvent 07 05 04 53.424 Quay Transport Ltd. (CK WMC 139/03) / JP Ryan (CK WMC

139/03)

Indaver Ireland Ltd. 36-2 AVG, Abfall-Verwertungs, Gesellschaft, Hamburg,Germany.

IB2234 D10

Waste solvent 07 05 04 39.9 Indaver Irl.-36-2. CK WMC 65/01 Indaver Ireland Ltd. 36-2 Indaver Irl.-36-2. CK WMC 65/01 36-2. CK WMC 65/01 D13

Waste solvent 07 05 04 580.18 Quay Transport Ltd. (CK WMC 139/03) / JP Ryan (CK WMC

139/03)

Indaver Ireland Ltd. 36-2 SRM, Hayhole Road, North Shields NE29 6DY, England.

BV4665IG R2

Waste solvent 07 05 04 9.327 Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd. 36-2 SRM, Solvent Resource Management , Middleton Rd, Morecambe , Lancashire , LA3

3JW, England.

BL73021D D10

Waste solvent 07 05 04 110.205 Quay Transport Ltd. (CK WMC 139/03) / JP Ryan (CK WMC

139/03)

Indaver Ireland Ltd. 36-2 Indaver NV, Polderlietweg, B-2030, Antwerp, Belgium.

EPA BV3120 D10

Mixed packaged waste 07 05 13 0.194 Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd. 36-2 AVG, Abfall-Verwertungs, Gesellschaft, Hamburg,Germany.

IB2234 D10

Mixed packaged waste 07 05 13 109.17 Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd. 36-2 Indaver NV, Polderlietweg, B-2030, Antwerp, Belgium.

MLAVI / 9800000485 D10

Waste hydraulic oil 130113 2.416 Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd. 36-2 Indaver NV, Polderlietweg, B-2030, Antwerp, Belgium.

MLAVI / 9800000485 D10

Waste hydraulic oil 130113 0.95 Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd. 36-2 AVG, Abfall-VerwertungsGesellschaft, Hamburg,

Germany.

IB2234 D10

Diesel and water 13 07 01 2.336 Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd. 36-2 Indaver NV, Polderlietweg, B-2030, Antwerp, Belgium.

MLAVI / 9800000485 D10

Contaminated packaging 15 01 10 0.094 Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd. 36-2 AVG, Abfall-Verwertungs, Gesellschaft, Hamburg,Germany.

IB2234 D10

36-2 MLAVI / 9800000485Mixed solvent waste 07 05 03 D10

MLAVI / 9800000485 D10Contaminated packaging 36-2

Quay Transport Ltd. (CK WMC 139/03) / JP Ryan (CK WMC

139/03)

15 01 10 20.137

Indaver NV, Polderlietweg, B-2030, Antwerp, Belgium.

Indaver NV, Polderlietweg, B-2030, Antwerp, Belgium.

217.492 Indaver Ireland Ltd.

Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd.

Page 72: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 Appendix B IPPC Licence Reg. No. P0004-03

Description of Waste EWC Code Tonnage Waste Haulier Waste Contractor/ Agent/Broker

Waste or IPC Permit or Licence

No.

Final destination Waste or IPPC Permit or Licence No.

Disposal or Recovery Code

Empty unclean metal drums 15 01 10 36.716 S-Transport(CK WMC 70/01) Indaver Ireland Ltd. 36-2 Rilta, Block 402, Greenogue Business Park, Rathcoole, Co. Dublin.

EPA W0192-1 R4

Contaminated filters, liners and PPE

15 02 02 0.025 Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd. 36-2 AVG, Abfall-VerwertungsGesellschaft, Hamburg,

Germany.

IB2234 D10

Contaminated filters, liners and PPE

15 02 02 4.183 Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd. 36-2 Indaver NV, Polderlietweg, B-2030, Antwerp, Belgium.

MLAVI / 9800000485 D10

Mixed solvent wastes from laboratory

160305 3.161 Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd. 36-2 AVG, Abfall-Verwertungs, Gesellschaft, Hamburg,Germany.

IB2234 D10

Mixed solvent wastes from laboratory

160305 0.972 Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd. 36-2 Indaver NV, Polderlietweg, B-2030, Antwerp, Belgium.

MLAVI / 9800000485 D10

Mixed solvent wastes from laboratory

16 05 06 0.939 Quay Transport Ltd. (CK WMC 139/03) / S Transport (CK WMC

70/03)

Indaver Ireland Ltd. 36-2 AVG, Abfall-VerwertungsGesellschaft, Hamburg,

Germany.

IB2234 D10

Mixed solvent wastes from laboratory

16 05 06 0.363 Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd. 36-2 Indaver NV, Polderlietweg, B-2030, Antwerp, Belgium.

MLAVI / 9800000485 D10

Inorganic liquid chemical waste

16 05 07 0.006 Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd. 36-2 AVG, Abfall-Verwertungs, Gesellschaft, Hamburg,Germany.

IB2234 D10

Inorganic liquid chemical waste

16 05 07 0.143 Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd. 36-2 Indaver NV, Polderlietweg, B-2030, Antwerp, Belgium.

MLAVI / 9800000485 D10

Mixed liquid chemical waste 16 05 08 0.545 Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd. 36-2 AVG, Abfall-Verwertungs, Gesellschaft, Hamburg,Germany.

IB2234 D10

Mixed liquid chemical waste 16 05 08 6.917 Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd. 36-2 Indaver NV, Polderlietweg, B-2030, Antwerp, Belgium.

MLAVI / 9800000485 D10

Catalyst 16 08 07 11.9 Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd. 36-2 Johnson Matthey PLC, 33 Jeffrey's Road, Enfield, Middlesex, EN3 7PW, UK.

253/93 R8

Hydrogen peroxide waste 16 09 03 0.006 Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd. 36-2 AVG, Abfall-Verwertungs, Gesellschaft, Hamburg,Germany.

IB2234 D10

Contaminated aqueous sludges

16 10 01 6.312 Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd. 36-2 Indaver NV, Polderlietweg, B-2030, Antwerp, Belgium.

MLAVI / 9800000485 D10

Incinerator lining 16 11 05 1.021 Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd. 36-2 Indaver NV, Polderlietweg, B-2030, Antwerp, Belgium

MLAVI / 9800000485 D9

Contaminated Pipework 17 04 09 1.978 Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd. 36-2 Indaver NV, Polderlietweg, B-2030, Antwerp, Belgium

MLAVI / 9800000485 D10

Contaminated Tiles 17 09 03 16.068 Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd. 36-2 Indaver NV, Polderlietweg, B-2030, Antwerp, Belgium

MLAVI / 9800000485 D10

Boiler dust 19 01 15 0.362 Quay Transport Ltd. (CK WMC 139/03)

Indaver Ireland Ltd. 36-2 Indaver NV, Polderlietweg, B-2030, Antwerp, Belgium.

MLAVI / 9800000485 D9

Fluourescent Tubes 20 01 21 0.38 Irish Lamp Ltd.(DC-08-1115-01) Indaver Ireland Ltd. 36-2 Irish Lamp Recycling, Blackpark, Kilkenny Road, Athy, Co. Kildare,

WFP-KE-0348-01 R4

Incineration on-site of halogenated

solvents

07 05 03 93 N/A N/A N/A GlaxoSmithKline, Currabinny, Carrigaline. IPPC P0004-03 D10

Incineration on-site of

non-halogenated solvents

07 05 04 2718 N/A N/A N/A GlaxoSmithKline, Currabinny, Carrigaline. IPPC P0004-03 D10

2811

Onsite reuse as fuel - halogenated

solvents

07 05 03 93 N/A N/A N/A GlaxoSmithKline, Currabinny, Carrigaline. IPPC P0004-03 R1

Total Incineration on-site

Page 73: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 Appendix B IPPC Licence Reg. No. P0004-03

Description of Waste EWC Code Tonnage Waste Haulier Waste Contractor/ Agent/Broker

Waste or IPC Permit or Licence

No.

Final destination Waste or IPPC Permit or Licence No.

Disposal or Recovery Code

Onsite reuse as fuel -

non- halogenated solvents

07 05 04 1453 N/A N/A N/A GlaxoSmithKline, Currabinny, Carrigaline. IPPC P0004-03 R1

Onsite solvent recovery - halogenated solvents

07 05 03 0 N/A N/A N/A GlaxoSmithKline, Currabinny, Carrigaline. IPPC P0004-03 R2

Onsite solvent recovery - non-halogenated solvents

07 05 04 660.2 N/A N/A N/A GlaxoSmithKline, Currabinny, Carrigaline. IPPC P0004-03 R2

2206.2

6590.35 %

2835.41 43

3754.944 57Total Hazardous Waste Disposed

Total Hazardous Waste Recovered

Total Solvent Recovery On-Site

Total Hazardous Waste Produced

Page 74: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

APPENDIX C

NON-HAZARDOUS WASTES ARISING ON SITE IN 2010

Page 75: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 Appendix C IPPC Licence Reg. No. P0004-03

Description of Waste

EWC Code Tonnage Waste Haulier Waste Contractor/

Agent/Broker

Waste or IPC Permit or Licence No.

Final destination Waste or IPPC Permit or

Licence No.

Disposal or Recovery Code

Fibre kegs 15 01 01 0.02 Greenstar Recycling Cork

(CK WMC 20/04)

Greenstar Recycling Cork

136-2 Greenstar Recycling (Cork), Sarsfieldcourt, Glanmire, Cork.

136-2 R3

Dry mixed recyclables

15 01 06 3.58 Greenstar Recycling Cork

(CK WMC 20/04)

Greenstar Recycling Cork

136-2 Greenstar Recycling (Cork), Sarsfieldcourt, Glanmire, Cork.

136-2 R3

C&D Waste 17 01 07 84 John Butler (CK WMC 169/03

Indaver Ireland Ltd.

36-2 John Butler, Riverstick, Co. Cork.

CK (S) 113/04 R5

C&D Waste 17 01 07 101.6 John Butler (CK WMC 169/03

Indaver Ireland Ltd.

36-2 John A. Wood, Killanully, Ballygarvan, Co. Cork.

CK (S) 88/04 R3

C&D Waste 17 01 07 167.32 S Transport Limited (CK WMC 70/03)

Indaver Ireland Ltd.

36-2 Greenstar Landfill, Knockharley, Co. Meath.

W0146-1 D1

Confidential paper

20 01 01 57.64 Cork Confidential Shredding (CK WMC 127/02

Cork Confidential Shredding

CK WMC 30-0 Cork Confidential ShreddingCCS Cork Limited, Unit K5,Marina Commercial Park,

Co. Cork.

CK (S) 288/06 R3

Paper and cardboard

20 01 01 17.68 Greenstar Recycling Cork

(CK WMC 20/04)

Indaver Ireland Ltd.

36-2 Greenstar Recycling (Cork),Sarsfieldcourt, Glanmire,

Cork.

136-2 R3

Food waste 20 01 08 1.89 Greenstar Recycling Cork

(CK WMC 20/04)

Greenstar Recycling (Cork)

136-2 Greenstar Composting Facility, Milltown,

Co. Tipperary.

WP 019 02 R10

Compost Waste 20 01 08 0.38 Greenstar Recycling Cork

(CK WMC 20/04)

Greenstar Recycling Cork

136-2 Acorn Recycling, Ballybeg Composting

Facility,Ballybeg,Littleton,County Tipperary

WO249-0 1 R10

Waste Cooking Oil

20 01 05 0.7 Frylite Ltd. (CKWMC 217/04

Indaver Ireland Ltd.

36-2 Frylite Ltd, Kilcoolgan, Co. Galway

WR/77 R9

Waste cable 20 01 36 32.78 Cork Metal Company Limited(CK WMC 26/06)

Cork Metal Company Limited

WP 08/02 Cork Metal Company Limited,Dublin Hill,

Cork.

WP 08/02 R4

Timber 20 01 38 71.76 Waste Recovery Services

(Fermoy) Ltd. (CK WMC 92/01) / S Transport Limited

Indaver Ireland Ltd.

36-2 Waste Recovery Services,Fermoy,

Co. Cork.

107-1 R3

Scrap metal - Stainless Steel

20 01 40 239.95 Cork Metal Company Limited (CKWMC 26/06)

Indaver Ireland Ltd.

36-2 Cork Metal Company Limited,Dublin Hill,

Cork.

WP 08/02 R4

Glass bottles and jars

20 01 02 5.64 Indaver Ireland Ltd.

Rehab Group (CK WMC 146/03

36-2 Rehab Recycling (Cork), Monahan Road, Cork.

03/07 R5

Page 76: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 Appendix C IPPC Licence Reg. No. P0004-03

Description of Waste

EWC Code Tonnage Waste Haulier Waste Contractor/

Agent/Broker

Waste or IPC Permit or Licence No.

Final destination Waste or IPPC Permit or

Licence No.

Disposal or Recovery Code

Waste Sludge 07 05 12 2.7 Greenstar Recycling Cork

(CK WMC 20/04)

Indaver Ireland Ltd.

36-2 Collins Waste Disposal, Farranbrien East, Minane

Bridge, Co. Cork.

CK (S) 18/02 D13

Waste Sludge 07 05 12 474.23 Greenstar Waste Management

Indaver Ireland Ltd.

36-2 Eras Eco, Foxhole, Youghal, Co. Cork

W0211-01 R13/R1

Mixed dry waste for landfill

20 03 07 102.85 Greenstar Recycling Cork

(CK WMC 20/04)

Indaver Ireland Ltd.

36-2 Greenstar Recycling (Cork), Sarsfieldcourt, Glanmire, Cork.

136-2 R5

1364.72

1194.7

170.02Total Non Hazardous Waste Disposed 2010

12

Total Non Hazardous Waste Produced 2010

%

Total Non Hazardous Waste Recovered 2010

88

Page 77: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

APPENDIX D

ENVIRONMENTAL MANAGEMENT PROGRAMME (EMP) 2011

Page 78: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

EMP 2011 IPPC Licence Reg. No. P0004-03

1

Environmental Management Programme (EMP) 2011 Condition 2.2.2.2 of IPPC Licence Reg. No. P0004-03 requires that GlaxoSmithKline (Cork) Ltd. maintain a Schedule of Environmental Objectives and Targets: “The Schedule shall as a minimum provide for a review of all operations and processes, including an evaluation of practicable options, for energy and resource efficiency, the use of cleaner technology, cleaner production, and the prevention, reduction and minimisation of waste, and shall include waste reduction targets. The Schedule shall include time frames for the achievement of set targets and shall address a five year period as a minimum.” Condition 2.2.2.3 of the licence requires that GSK Cork maintain an Environmental Management Programme (EMP) for the achievement of the Objectives and Targets prepared under the Schedule above. The Schedule and the EMP shall be reviewed annually and amendments thereto notified to the EPA for agreement as part of the Annual Environmental Report. This EMP describes the method and time frame in which GSK aims to complete these objectives. The EMP comprises a number of categories as follows:

1. Environmental Management System Review

2. Emissions to Atmosphere of Volatile Organic Compounds

3. Waste Management (Solid and Liquid)

4. Surface Water Quality & Number of diversions

5. Incinerator Wastewater & Bioplant Effluent Quality

6. Groundwater Quality

7. Energy reduction

8. Reduction in water usage.

For each of these headings the following information is outlined:

• Objective

• Rationale behind objective

• Specific targets to achieve objective

• Plan to achieve targets

• Time scale

• Teams responsible.

Page 79: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

EMP 2011 IPPC Licence Reg. No. P0004-03

2

1.0 Objective Environmental Management System Review

Rationale: Modify EMS as needs be to address compliance issues & continue to improve system

NO. Target Plan Time scale Responsibility

1.1 Achieve certification to ISO14000

Review all site processes and conduct gap analysis against standard.

Q2 2011 SEHS

1.2 Optimise incident investigation process

Use Operation excellence tools – 5 why, 5 W&H, Fish Bone etc to investigate root causes of EPA reportable incidents.

Q1 2011 Site & SEHS

2.0 Objective Emissions to atmosphere (Volatile Organic Compounds).

Rationale: To control and prevent emissions of Volatile Organic Compounds from site activities being detected off-site.

NO. Target Plan Time scale Responsibility

2.1 Prevent emission of Volatile Organic Compounds (VOC) from SCR 1901.

Maximise Incinerator uptime (Target 99.3%)

Manage Bypass emissions to ensure Air quality limits (Ground level concentration) are complied with.

Q4 2011 SEHS

Page 80: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

EMP 2011 IPPC Licence Reg. No. P0004-03

3

3.0 Objective To manage liquid and solid waste on-site to meet all IPPC Licence requirements and to identify additional waste reduction, recovery and recycling opportunities.

Rationale: To ensure compliance with IPPC Licence, GSK Corporate and Legislative requirements.

NO. Target Plan Time scale Responsibility

3.1 To assess external waste facilities accepting GSK Cork waste.

Audit two external waste handling facilities.

Q4 2011 SEHS

3.2 Carry out an assessment of current and future solvent recovery opportunities.

Based on business projections, review solvents in use on current & future proposed processes for recovery feasibility (environmental, technical & financial).

Q4 2011, this is an annual review as part of NCE

blitz

Technical Operations

3.4 Review alternatives to incineration

Produce a high level cost on possible alternatives to incineration

Q3 2011 C&PE

3.5 Sustainability Kaisen Event Carry out Kaisen Event with a view to identifying all sustainability opportunities including waste minimisation.

Q2 2011 SEHS

3.6 Improve the efficiency of the WWTP

Complete WWTP upgrade project (downsizing of aeration capacity to match demand).

Q2 2011 SEHS

Page 81: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

EMP 2011 IPPC Licence Reg. No. P0004-03

4

4.0 Objective To protect the quality of surface water.

Rationale: To prevent the contamination of surface water.

NO. Target Plan Time scale Responsibility

4.1 To reduce TOC in surface water from site.

1. Monitor TOC quality.

2. Maintain awareness of surface water quality across the site.

3. Act on significant TOC contaminations.

4. Investigate root causes of spills where possible.

Q4 2011

SEHS / Process Dept.

4.2 To reduce the frequency of SW diversions to biotreatment

1. Monitor diversion count.

2. Surface water diversion count to be reduced

3. Integrity test SW pipeline network.

4. Repair damaged/rogue lines

Q4 2011

SEHS / Process Dept.

5.0 Objective To protect the quality of incinerator wastewater emissions

Rationale: To ensure IPPC compliance with all parameters in both streams.

NO. Target Plan Time scale Responsibility

5.1

Review options to remove salt from waste streams

Determine opportunities based on the GSK Jurong delsalination project

Q4 2011 SEHS

Page 82: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

EMP 2011 IPPC Licence Reg. No. P0004-03

5

6.0 Objective To protect the quality of groundwater.

Rationale: To protect the quality of groundwater sources beneath the site and prevent contamination.

NO. Target Plan Time scale Responsibility

6.1 To monitor groundwater quality. Biannual sampling analysis. 2011 SEHS

6.2 Continue to monitor levels of ammonium and bacteriological levels in groundwater

Monitor levels of contaminants 2011 SEHS & Engineering

6.3 To ensure maximum protection of groundwater quality on-site by carrying out remediation of any ruptured underground lines identified.

Carry out repairs / remediation on underground pipelines as required.

2011 and on ongoing basis

Engineering

7.0 Objective Reduction in energy requirements for GSK Cork site

Rationale: To reduce the energy requirements for the operations on site

NO. Target Plan Time scale Responsibility

7.1 Reduce natural gas consumption Continue implementation of Waste Accountability Improvement Project across the site – reduction in water content of liquid waste for incineration will reduce the fuel requirement (natural gas consumption).

Q4 2011 SEHS & Technical

Development Teams

7.2 Reduce electricity consumption Operate Incinerator No.3 in Thermal Oxidiser mode when there is no liquid waste to be incinerated

Qtr3 2011 SEHS and Technical Development Teams

Page 83: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

EMP 2011 IPPC Licence Reg. No. P0004-03

6

7.0 Objective Reduction in energy requirements for GSK Cork site

Rationale: To reduce the energy requirements for the operations on site

NO. Target Plan Time scale Responsibility

7.3 Monitor key energy usage areas for trends

The site metering system will be used to analyse the trends in usages in high usage areas around the site to facilitate future improvements in efficiency.

2011 and onwards

Energy & Utilities Champion and

Building Owners

7.3 Reduce natural gas consumption Implement recommendations from Armstrong Steam Audit report in order to improve efficiency of steam distribution system.

Q3 2011 Engineering Team

7.4 Divert stream from incineration to WWTP

Assess biodegradability of certain aqueous waste streams (Lap3 and P 6/7).

Route to bioplant instead of incineration

Q2 2011 SEHS and Technical Development Teams

7.5 Source alternative high CV waste stream to reduce incinerator gas consumption

Investigate opportunity for third party waste to support incineration during periods of low volumes of high CV waste

Q4 2011 SEHS and Technical Development Teams

Page 84: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

EMP 2011 IPPC Licence Reg. No. P0004-03

7

8.0 Objective Reduction in water requirements for GSK Cork site

Rationale: To reduce the water requirements for the operations on site

NO. Target Plan Time scale

Responsibility

8.1 Reduce leakage of mains water

Continue to investigate and repair leaks on underground firewater main.

Q2 2011 Engineering Services

8.2 Reduce use of mains water on Incinerator quench

Carry out feasibility study on use of redundant aeration basin for storing rainwater & acceptable grade of waste water which could then be used as quench water on Incinerator.

Q4 2011 Capital & Projects & EHS Teams

Page 85: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

APPENDIX E

ENVIRONMENTAL MANAGEMENT PROGRAMME (EMP) PROGRESS REPORT 2010

Page 86: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

EMP 2010 Report IPPC Licence Reg. No. P0004-03

1

Report on the Environmental Management Programme (EMP) during 2010 Condition 2.2.2.2 of IPPC Licence Reg. No. P0004-03 requires that GlaxoSmithKline (Cork) Ltd. maintain a Schedule of Environmental Objectives and Targets. The Schedule shall, at a minimum, provide for a review of all operations and processes, including an evaluation of practicable options, for energy and resource efficiency, the use of cleaner technology, cleaner production, and the prevention, reduction and minimisation of waste, and shall include waste reduction targets. The Schedule shall include time frames for the achievement of set targets and shall address a five-year period at a minimum. Condition 2.2.2.3 of the licence requires that GSK Cork maintain an Environmental Management Programme (EMP) for the achievement of the Objectives and Targets prepared under the Schedule above. The Schedule and the EMP shall be reviewed annually and amendments thereto notified to the EPA for agreement as part of the Annual Environmental Report. This EMP describes the method and time frame in which GSK aims to complete these objectives. The 2010 EMP comprises a number of categories as follows:

1. Environmental Management System Review

2. Emissions to Atmosphere of Volatile Organic Compounds

3. Waste Management (Solid and Liquid)

4. Surface Water Quality & Number of diversions

5. Incinerator Wastewater & Bioplant Effluent Quality

6. Groundwater Quality

7. Energy reduction

8. Reduction in water usage.

For each of these headings the following information is outlined:

• Objective

• Rationale behind objective

• Specific targets to achieve objective

• Plan to achieve targets

• Time scale

• Teams responsible.

Page 87: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

EMP 2010 Report IPPC Licence Reg. No. P0004-03

2

1.0 Objective Environmental Management System Review

Rationale: Modify EMS as needs be to address compliance issues & continue to improve system

NO. Target Plan Progress achieved during 2010 1.1 Update EHS procedures to

comply with current/new regulations.

Modify EMS to include details of IPPC licence. Procedures have been upgraded to reflect updates in: (i) IS14181 CEMS testing (ii) Management of changeover from

Incinerator to thermal oxidiser (iii) Bypass emissions/incident

notification 1.2 Train personnel on IPPC

licence and additional new regulations to relevant groups onsite.

Carry out training sessions as required. Licence Training was carried out to all production operators (approx 100 staff)

1.3 Optimise incident investigation process

Use Operation Excellence tools – 5 Why, 5 W&H, Fish bone etc to investigate root causes of EPA reportable incidents.

OE tools are now fully in use & working well in root cause investigation

Page 88: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

EMP 2010 Report IPPC Licence Reg. No. P0004-03

3

2.0 Objective Emissions to atmosphere (Volatile Organic Compounds).

Rationale: To control and prevent emissions of Volatile Organic Compounds from site activities being detected off-site.

NO. Target Plan Progress achieved during 2010 2.1 Prevent emission of Volatile

Organic Compounds (VOC) from SCR 1901.

Maximise Incinerator uptime (Target 99.5%) Minimise incinerator bypass time (Target <80hours) Manage Bypass emissions to ensure air quality limits (Ground level concentration) are complied with.

Uptime 99.27% (One incinerator in operation only at any time in 2010) 149.9hours on bypass (see note above – hours on bypass above target but emission levels very low) Bypass emissions <5% GLC limits at any time. (478.1kg VOCs to atmosphere via bypass – low production volumes resulted in low number of processes on line when on bypass)

2.2 Reduce fugitive solvent emissions from storage tanks. There are fugitive emissions from virgin and recovered tanks when backloading from road tankers.

Complete the project to route fugitive solvent emissions ex THF, Ethyl acetate and MDC (virgin) solvent storage tanks from atmosphere to incinerator via Lean Gas Header.

Project was completed in 2009

Page 89: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

EMP 2010 Report IPPC Licence Reg. No. P0004-03

4

3.0 Objective To manage liquid and solid waste on-site to meet all IPPC Licence requirements and to identify additional

waste reduction, recovery and recycling opportunities.

Rationale: To ensure compliance with IPPC Licence, GSK Corporate and Legislative requirements.

NO. Target Plan Progress achieved during 2010 3.1 To assess external waste

facilities accepting GSK Cork waste.

Audit two external waste handling facilities.

Two external waste facilities and one waste haulier audits were carried and deemed satisfactory.

3.2 Carry out an assessment of current and future solvent recovery opportunities.

Based on business projections, review solvents in use on current & future proposed processes for recovery feasibility (environmental, technical & financial).

Consistently carried out. All new products are assessed for recovery opportunities.

3.3 Carry out a review of technology with a view to reducing waste generation.

Review technology use onsite on solvent recovery abatement, wastewater treatment, etc., with a view to improving waste minimisation.

Corporate team looks at new technologies e.g. supercritical oxidation, chemical oxidation, ozonation etc. for suitability.

3.4 Reduce waste formation at source where possible.

1 Investigate opportunities for waste reduction at source. 2. Resource projects to implement waste reductions

In 2010 Total Waste Management (TWM) introduced the following initiatives: • Installed a bin press which reduced

the amount of collections per year • Installed a paint tin press • Rerouted landscape waste from

landfill to composting. • Refresher training conducted with

120 GSK operators on waste baling and labeling of waste onsite with respect to ADR and IMDG Regulations.

• Indaver Indascan project activated, allowing for real time inventory of contents in Waste Drum Park

Page 90: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

EMP 2010 Report IPPC Licence Reg. No. P0004-03

5

4.0 Objective To protect the quality of surface water.

Rationale: To prevent the contamination of surface water.

NO. Target Plan Progress achieved during 2010 4.1 To reduce TOC in surface

water from site. (2009 average 28 mg/L).

1. Monitor TOC quality. 2. Maintain awareness of surface water quality across the site. 3. Act on significant TOC contaminations. 4. Investigate root causes of spills where possible.

1. SW quality reviewed during weekly performance reviews 2. Review at regular cross functional performance reviews & at operations daily reviews 3. & 4. High TOC investigated for source & shutdown. Contractor generators & vehicles use spill trays. Spills investigated.

4.2 To reduce the frequency of SW diversions to biotreatment

1. Monitor diversion count. 2. Surface water diversion count to be reduced by 20% in 2010 (from 120 to 96). 3. Integrity test SW pipeline network. 4. Repair damaged/rogue lines

1. Reviewed at weekly performance review 2. Diversion count reduced by 40% from 120 in 2009 to 72 in 2010. 3. & 4. Underground pipeline testing/remediation continued in 2010

Page 91: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

EMP 2010 Report IPPC Licence Reg. No. P0004-03

6

5.0 Objective To protect the quality of incinerator wastewater emissions

Rationale: To ensure IPPC compliance with all parameters in both streams.

NO. Target Plan Progress achieved during 2010 5.1 Minimise TSS EPA reportable

incidents. 1. Optimise the incinerator wastewater caustic control to reduce pH excursions that lead to water hardness solids precipitating. 2. Install air diffusers in waste tanks to ensure improved mixing of wastes & reduced ‘layering’.

1. Quench pH control further improved during a series of 31 reportable (>45mg/l) incidents in 2010 2. Air diffusers installed which reduces layering of MDC & reduces HCl concentration in quench.

5.2 To achieve minimum non-compliances due to high suspended solids in incinerator wastewaters in 2010.

Analyse Incinerator wastewater for metals as per Schedule B.2 (W1) of IPPC licence when solids are >45mg/l ELV.

Failing quench samples are analysed for metals for each reportable incident. No failing level of metals has been recorded.

6.0 Objective To protect the quality of groundwater.

Rationale: To protect the quality of groundwater sources beneath the site and prevent contamination.

NO. Target Plan Progress achieved during 2010 6.1 To monitor groundwater

quality. Biannual sampling analysis. Biannual monitoring completed.

6.2 Reduce ammonium and bacteriological levels in the groundwater.

1. Monitor levels of contaminants. 2. Pump and biotreat. 3. Fix foul pipeline leaks where necessary.

Contaminants reviewed at performance review meetings & low level concentrations were reported. No evidence of recent spills in 2010 provided evidence that foul pipeline fix in 2009 was successful

6.3 To ensure maximum protection of groundwater quality on-site by carrying out remediation of any ruptured underground lines identified.

Carry out repairs / remediation on underground pipelines as required.

Underground pipeline testing & remediation continued in 2010.

Page 92: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

EMP 2010 Report IPPC Licence Reg. No. P0004-03

7

7.0 Objective Reduction in energy requirements for GSK Cork site Rationale: To reduce the energy requirements for the operations on site NO. Target Plan Progress achieved during 2010 7.1 Reduce natural gas

consumption Continue implementation of Waste Accountability Improvement Project across the site – reduction in water content of liquid waste for incineration will reduce the fuel requirement (natural gas consumption).

A system was put in place to record actual water usage versus planned water usage for cleaning and validation activities.

7.2 Reduce natural gas and electricity consumption

Modify Incinerator No.3 to allow it operate in Thermal Oxidiser mode when there is no liquid waste to be incinerated

Incinerator No.3 was modified to allow it to operate in Thermal Oxidiser mode.

7.3 Monitor key energy usage areas for trends

The site metering system will be used to analyse the trends in usages in high usage areas around the site to facilitate future improvements in efficiency.

Building Owners appointed to monitor energy use in key areas. Improvements made in electricity metering infrastructure.

8.0 Objective Reduction in water requirements for GSK Cork site Rationale: To reduce the water requirements for the operations on site NO. Target Plan Progress achieved during 2010 8.1 Reduce leakage of mains water Continue to investigate and repair leaks on

underground firewater main. All major leaks on underground firewater main were identified and repaired.

8.2 Reduce use of mains water on Incinerator quench

Carry out feasibility study on use of redundant aeration basin for storing rainwater & acceptable grade of waste water which could then be used as quench water on Incinerator.

Feasibility study postponed due to WWTP upgrade. Due to be completed in 2011

Page 93: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03

APPENDIX F

PRTR AND AER SUMMARY DATA TABLES FOR 2010

Page 94: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

Sheet : Facility ID Activities AER Returns Workbook 16/3/2011 17:10

| PRTR# : P0004 | Facility Name : Smithkline Beecham (Cork) Limited | Filename : P0004_2010.xlsm | Return Year : 2010 | 3313 16/03/2011 17:31

Guidance to completing the PRTR workbook

Version 1.1.11REFERENCE YEAR 2010

1. FACILITY IDENTIFICATIONParent Company Name Smithkline Beecham (Cork) Limited

Facility Name Smithkline Beecham (Cork) LimitedPRTR Identification Number P0004

Licence Number P0004-03

Waste or IPPC Classes of ActivityNo. class_name

5.16The use of a chemical or biological process for the production of basic pharmaceutical products.

11.1 ######################################################

Address 1 CurrabinnyAddress 2 CarrigalineAddress 3 County CorkAddress 4

Country IrelandCoordinates of Location -8.31547 51.8169

River Basin District IESWNACE Code 2120

Main Economic Activity Manufacture of pharmaceutical preparationsAER Returns Contact Name Dermot Quirke

AER Returns Contact Email Address [email protected] Returns Contact Position EHS Engineer

AER Returns Contact Telephone Number 021 4512316AER Returns Contact Mobile Phone Number

AER Returns Contact Fax Number 021-4378560Production Volume 85.0

Production Volume Units metric tonnesNumber of Installations 1

Number of Operating Hours in Year 8232Number of Employees 361

User Feedback/CommentsWeb Address

2. PRTR CLASS ACTIVITIESActivity Number Activity Name

4(e)Installations using a chemical or biological process for the production on an industrial scale of basic pharmaceutical products

50.1 General

3. SOLVENTS REGULATIONS (S.I. No. 543 of 2002)Is it applicable? No

Have you been granted an exemption ? NoIf applicable which activity class applies (as per

Schedule 2 of the regulations) ?Is the reduction scheme compliance route being

used ?

AER Returns Workbook

| PRTR# : P0004 | Facility Name : Smithkline Beecham (Cork) Limited | Filename : P0004_2010.xlsm | Return Year : 2010 | Page 1 of 1

Page 95: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

Sheet : Releases to Air AER Returns Workbook 15/3/2011 9:41

4.1 RELEASES TO AIR Link to previous years emissions data | PRTR# : P0004 | Facility Name : Smithkline Beecham (Cork) Limited | Filename : P0004_2010.xlsm | Return Year : 2010 | 16/03/2011 17:458 16 24 28 36 44 6 9 6 7 6 8 38

SECTION A : SECTOR SPECIFIC PRTR POLLUTANTSPlease enter all quantities in this section in KGs

QUANTITYA2-1 (Incinerator No.1) A2-3A (Incinerator No3)

No. Annex II Name M/C/E Method Code Designation or Description Emission Point 1 Emission Point 2 Emission Point 3 Emission Point 4 T (Total) KG/YearA (Accidental) KG/Year

F (Fugitive) KG/Year

0.0 0.0 0.0 0.0 0.0 0.0 0.011 Sulphur oxides (SOx/SO2) M ISO 7935: 1992 61.89 27.19 0.0 0.0 89.08 0.0 0.008 Nitrogen oxides (NOx/NO2) M EN 14792:2005 EN 14792:2006 273.32 1307.92 0.0 0.0 1581.24 0.0 0.007 Non-methane volatile organic compounds (NMVOC) C OTH US EPA AP42 - tanks 4.0 0.0 0.0 0.0 0.0 480.06 0.0 480.06

03 Carbon dioxide (CO2) C OTHNatural gas & bioplant emission calculation 0.0 0.0 0.0 0.0 16791.0 0.0 16791.0

80 Chlorine and inorganic compounds (as HCl) M EN 1911-1 to 3:2003 IS EN 1911:2010 8.59 15.54 0.0 0.0 24.13 0.0 0.047 PCDD + PCDF (dioxins + furans)(as Teq) M ALT BS EN 1948-1:2006 0.0 0.000000028 0.0 0.0 0.000000028 0.0 0.019 Chromium and compounds (as Cr) M EN 14385:2004 BS EN 14385:2004 0.1588 0.0233 0.0 0.0 0.1821 0.0 0.020 Copper and compounds (as Cu) M EN 14385:2004 BS EN 14385:2004 0.05 0.0425 0.0 0.0 0.0925 0.0 0.0

* Select a row by double-clicking on the Pollutant Name (Column B) then click the delete button

SECTION B : REMAINING PRTR POLLUTANTSPlease enter all quantities in this section in KGs

QUANTITYA2-1 (Incinerator No.1) A2-3A (Incinerator No.3)

No. Annex II Name M/C/E Method Code Designation or Description Emission Point 1 Emission Point 2 T (Total) KG/YearA (Accidental) KG/Year

F (Fugitive) KG/Year

0.0 0.0 0.0 0.0 0.002 Carbon monoxide (CO) M EN 15058:2004 EN 15058:2006 13.76 1.24 15.0 0.0 0.084 Fluorine and inorganic compounds (as HF) M OTH US EPA AP26 & 26A 0.03 0.53 0.56 0.0 0.0

0.0 0.0 0.0 0.0 0.073 Toluene C OTH US EPA AP42 - tank 4.0 0.0 0.0 40.0 0.0 40.0

* Select a row by double-clicking on the Pollutant Name (Column B) then click the delete button

SECTION C : REMAINING POLLUTANT EMISSIONS (As required in your Licence)Please enter all quantities in this section in KGs

QUANTITYA2-1 (incinerator No.1) A2-3A (incinerator No.3)

Pollutant No. Name M/C/E Method Code Designation or Description Emission Point 1 Emission Point 2 Emission Point 3 T (Total) KG/YearA (Accidental) KG/Year

F (Fugitive) KG/Year

0.0 0.0 0.0 0.0 0.0 0.0351 Total Organic Carbon (as C) M OTH IS EN 12619:1999 4.62 2.12 0.0 6.74 0.0 0.0210 Dust M OTH EN 13284-2 0.0 0.0 0.0 0.0 0.0 0.0214 Hydrogen bromide M OTH US EPA AP26&26A 2.03 8.3 0.0 10.33 0.0 0.0230 TA Luft organic substances class 1 M OTH FTIR 0.0 0.0 0.0 45.42 0.0 45.42231 TA Luft organic substances class 2 M OTH FTIR 0.0 0.0 0.0 299.54 0.0 299.54232 TA Luft organic substances class 3 M OTH FTIR 0.0 0.0 0.0 563.06 0.0 563.06356 Cobalt M EN 14385:2004 0.0005823 0.0004279 0.0 0.0010102 0.0 0.0321 Manganese (as Mn) M EN 14385:2004 0.0 0.052 0.0 0.052 0.0 0.0

* Select a row by double-clicking on the Pollutant Name (Column B) then click the delete button

Additional Data Requested from Landfill operators

Landfill: Smithkline Beecham (Cork) Limited

Please enter summary data on the quantities of methane flared and / or utilised

additional_pollutant_no T (Total) kg/Year M/C/E Method Code Designation or DescriptionFacility Total Capacity m3

per hourTotal estimated methane generation (as per site

model) 0.0 N/AMethane flared 0.0 0.0 (Total Flaring Capacity)

Methane utilised in engine/s 0.0 0.0 (Total Utilising Capacity)Net methane emission (as reported in Section A

above) 0.0 N/A

RELEASES TO AIR

RELEASES TO AIR

POLLUTANT METHODMethod Used

RELEASES TO AIRPOLLUTANT METHOD

Method Used

Method Used

Method UsedPOLLUTANT METHOD

For the purposes of the National Inventory on Greenhouse Gases, landfill operators are requested to provide summary data on landfill gas (Methane) flared or utilised on their facilities to accompany the figures for total methane generated. Operators should only report their Net methane (CH4) emission to the environment under T(total) KG/yr for Section A: Sector specific PRTR pollutants above. Please complete the table below:

| PRTR# : P0004 | Facility Name : Smithkline Beecham (Cork) Limited | Filename : P0004_2010.xlsm | Return Year : 2010 | Page 1 of 1

Page 96: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

Sheet : Releases to Waters AER Returns Workbook 15/3/2011 9:42

4.2 RELEASES TO WATERS Link to previous years emissions data | PRTR# : P0004 | Facility Name : Smithkline Beecham (Cork) Limited | Filename : P0004_2010.xlsm | Return Year : 2010 | 16/03/2011 17:118 16 24 24 32 38 6 6 6 6 6 6 38

SECTION A : SECTOR SPECIFIC PRTR POLLUTANTS Data on ambient monitoring of storm/surface water or groundwater, conducted as part of your licence requirements, should NOT be submitted under AER / PRTR Reporting as this only concerns Releases from your facilityPlease enter all quantities in this section in KGs

QUANTITY

No. Annex II Name M/C/E Method Code Designation or Description Emission Point 1 T (Total) KG/Year A (Accidental) KG/Year F (Fugitive) KG/Year0.0 0.0 0.0 0.0

12 Total nitrogen M EN 12260:2003 BS EN 12260:2003d 1749.3 1749.3 0.0 0.0

13 Total phosphorus MEN ISO 6878:2004 BS EN 6878:2004 395.0 395.0 0.0 0.0

24 Zinc and compounds (as Zn) M OTH AA 4.8 4.8 0.0 0.023 Lead and compounds (as Pb) M OTH ICP 1.029 1.029 0.0 0.022 Nickel and compounds (as Ni) M OTH AA 1.228 1.228 0.0 0.020 Copper and compounds (as Cu) M OTH AA1.2 1.2 1.2 0.0 0.019 Chromium and compounds (as Cr) M OTH ICP 1.15 1.15 0.0 0.047 PCDD + PCDF (dioxins + furans)(as Teq) M ALT BS EN 1948-1:2006 0.0 0.0 0.0 0.0

* Select a row by double-clicking on the Pollutant Name (Column B) then click the delete button

SECTION B : REMAINING PRTR POLLUTANTSPlease enter all quantities in this section in KGs

QUANTITY

No. Annex II Name M/C/E Method Code Designation or Description Emission Point 1 T (Total) KG/Year A (Accidental) KG/Year F (Fugitive) KG/Year0.0 0.0 0.0 0.0

* Select a row by double-clicking on the Pollutant Name (Column B) then click the delete button

SECTION C : REMAINING POLLUTANT EMISSIONS (as required in your Licence)Please enter all quantities in this section in KGs

QUANTITY

Pollutant No. Name M/C/E Method Code Designation or Description Emission Point 1 T (Total) KG/Year A (Accidental) KG/Year F (Fugitive) KG/Year0.0 0.0 0.0 0.0

351 Total Organic Carbon (as C) M OTH FID 6953.982 6953.982 0.0 0.0306 COD M ALT ISO15705:2002 51553.0 51553.0 0.0 0.0240 Suspended Solids M ALT EN872:2005 2480.0 2480.0 0.0 0.0303 BOD M ALT APHA ETO662 497.0 497.0 0.0 0.0238 Ammonia (as N) M ALT ISO6778-1984 103.0 103.0 0.0 0.0327 Nitrate (as N) M ALT APHA 4500-NO3E 130.0 130.0 0.0 0.0

* Select a row by double-clicking on the Pollutant Name (Column B) then click the delete button

Method Used

POLLUTANTMethod Used

POLLUTANT

POLLUTANTRELEASES TO WATERS

Method Used

RELEASES TO WATERS

RELEASES TO WATERS

| PRTR# : P0004 | Facility Name : Smithkline Beecham (Cork) Limited | Filename : P0004_2010.xlsm | Return Year : 2010 |

Page 97: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

Sheet : Releases to Wastewater or Sewer AER Returns Workbook 15/3/2011 9:43

4.3 RELEASES TO WASTEWATER OR SEWER Link to previous years emissions data | PRTR# : P0004 | Facility Name : Smithkline Beecham (Cork) Limited | Filename : P0004_2010.xlsm | R8 8 16 16 6 6 6 6

SECTION A : PRTR POLLUTANTSPlease enter all quantities in this section in KGs

QUANTITY

No. Annex II Name M/C/E Method Code Designation or Description Emission Point 1 T (Total) KG/Year A (Accidental) KG/Year0.0 0.0 0.0

* Select a row by double-clicking on the Pollutant Name (Column B) then click the delete button

SECTION B : REMAINING POLLUTANT EMISSIONS (as required in your Licence)Please enter all quantities in this section in KGs

QUANTITY

Pollutant No. Name M/C/E Method Code Designation or Description Emission Point 1 T (Total) KG/Year A (Accidental) KG/Year0.0 0.0 0.0

* Select a row by double-clicking on the Pollutant Name (Column B) then click the delete button

OFFSITE TRANSFER OF POLLUTANTS DESTINED FOR WASTE-WATER TREATMENT OR SEWER

OFFSITE TRANSFER OF POLLUTANTS DESTINED FOR WASTE-WATER TREATMENT OR SEWER

Method Used

Method Used

POLLUTANT METHOD

POLLUTANT METHOD

Link to previous years emissions data

Page 98: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

Sheet : Releases to Land AER Returns Workbook 15/3/2011 9:44

4.4 RELEASES TO LAND Link to previous years emissions data | PRTR# : P0004 | Facility Name : Smithkline Beecham (Cork) Limited | Filename : P0004_2010.xlsm | Return Year : 2010 | 16/03/2011 17:118 8 16 16 6 6 6 6

SECTION A : PRTR POLLUTANTSPlease enter all quantities in this section in KGs

QUANTITY

No. Annex II Name M/C/E Method Code Designation or Description Emission Point 1 T (Total) KG/Year A (Accidental) KG/Year0.0 0.0 0.0

* Select a row by double-clicking on the Pollutant Name (Column B) then click the delete button

SECTION B : REMAINING POLLUTANT EMISSIONS (as required in your Licence)Please enter all quantities in this section in KGs

QUANTITY

Pollutant No. Name M/C/E Method Code Designation or Description Emission Point 1 T (Total) KG/Year A (Accidental) KG/Year0.0 0.0 0.0

* Select a row by double-clicking on the Pollutant Name (Column B) then click the delete button

POLLUTANT METHODMethod Used

RELEASES TO LAND

RELEASES TO LAND

POLLUTANT METHODMethod Used

| PRTR# : P0004 | Facility Name : Smithkline Beecham (Cork) Limited | Filename : P0004_2010.xlsm | Return Year : 2010 |

Page 99: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

Sheet : Treatment Transfers of Waste AER Returns Workbook 15/3/2011 9:45

5. ONSITE TREATMENT & OFFSITE TRANSFERS OF WASTE | PRTR# : P0004 | Facility Name : Smithkline Beecham (Cork) Limited | Filename : P0004_2010.xlsm | Return Year : 2010 | 16/03/2011 17:115 66 Please enter all quantities on this sheet in Tonnes 25

Quantity (Tonnes per

Year)

Haz Waste : Name and Licence/Permit No of Next

Destination Facility Non Haz Waste: Name and Licence/Permit No of

Recover/Disposer

Haz Waste : Address of Next Destination Facility

Non Haz Waste: Address of Recover/Disposer

Name and License / Permit No. and Address of Final Recoverer /

Disposer (HAZARDOUS WASTE ONLY)

Actual Address of Final Destination i.e. Final Recovery / Disposal Site (HAZARDOUS WASTE ONLY)

Transfer DestinationEuropean Waste

Code Hazardous Quantity T/Year Description of Waste

Waste Treatment Operation M/C/E Method Used

Location of Treatment Name and Licence / Permit No. of Recoverer / Disposer / Broker Address of Recoverer / Disposer / Broker Name and Address of Final Destination i.e. Final Recovery / Disposal Site (HAZARDOUS WASTE ONLY) Licence / Permit No. of Final Destination i.e. Final Recovery / Disposal Site (HAZARDOUS WASTE ONLY)

Within the Country 15 01 01 No 0.02 paper and cardboard packaging R3 M Weighed Offsite in IrelandGreenstar Recycling Cork,136-2

Sarsfieldcourt,Glanmire ,Cork,.,Ireland

Within the Country 15 01 06 No 3.58 mixed packaging R3 M Weighed Offsite in IrelandGreenstar Recycling Cork,136-2

Sarsfieldcourt,Glanmire ,Cork,.,Ireland

Within the Country 17 01 07 No 84.0

mixture of concrete, bricks, tiles and ceramics other than those mentioned in 17 01 06 R5 M Weighed Offsite in Ireland John Butler,CK(S) 113/04 Riverstick,Co. Cork,.,.,Ireland

Within the Country 17 01 07 No 101.6

mixture of concrete, bricks, tiles and ceramics other than those mentioned in 17 01 06 R3 M Weighed Offsite in Ireland John A. Wood,CK(S) 88/04

Killanully,Ballygarvan,Co. Cork,.,Ireland

Within the Country 17 01 07 No 167.32

mixture of concrete, bricks, tiles and ceramics other than those mentioned in 17 01 06 D1 M Weighed Offsite in Ireland Greenstar Landfill,WO 146-1

Knockharley,Co. Meath,.,.,Ireland

Within the Country 20 01 01 No 57.64 paper and cardboard R3 M Weighed Offsite in IrelandCork Confidential Shredding,CK (S) 288/06

Unit K5,Marina Commercial Park,Co. Cork,.,Ireland

Within the Country 20 01 02 No 5.64 glass R5 M Weighed Offsite in IrelandRehab Recycling Cork,07/03/2011

Monahan Road,Cork,.,.,Ireland

Within the Country 20 01 01 No 17.68 paper and cardboard R3 M Weighed Offsite in IrelandGreenstar Recycling Cork,136-2

Sarsfieldcourt,Glanmire ,Cork,.,Ireland

Within the Country 20 01 08 No 1.89 biodegradable kitchen and canteen waste R10 M Weighed Offsite in IrelandGreenstar Composting Facilty ,WP 019 02

Milltown ,Co. Tipperary,.,.,Ireland

Within the Country 20 01 08 No 0.38 biodegradable kitchen and canteen waste R10 M Weighed Offsite in IrelandAcorn Recycling Ballybeg Composting,WO249-01

Ballybeg,Littleton,Co. Tipperary,.,Ireland

Within the Country 20 01 25 No edible oil and fat R9 M Weighed Offsite in Ireland Frylite Ltd,WR/77Kilcoolgan,Co. Galway,.,.,Ireland

Within the Country 20 01 36 No 32.78

discarded electrical and electronic equipment other than those mentioned in 20 01 21, 20 01 23 and 20 01 35 R4 M Weighed Offsite in Ireland

Cork Metal Company Ltd.,WP 08/02 Dublin Hill,Cork,.,.,Ireland

Within the Country 20 01 38 No 71.76 wood other than that mentioned in 20 01 37 R3 M Weighed Offsite in IrelandWaste Recovery Services,107-1 Fermoy,Co. Cork,.,.,Ireland

Within the Country 20 01 40 No 239.95 metals R4 M Weighed Offsite in IrelandCork Metal Company Ltd.,WP 08/02 Dublin Hill,Cork,.,.,Ireland

Within the Country 07 05 12 No 2.7sludges from on-site effluent treatment other than those mentioned in 07 05 11 D13 M Weighed Offsite in Ireland

Collins Waste Disposal ,CK(S) 18/02

Farranbrien East,Minnane Bridge,Co. Cork,.,Ireland

Within the Country 07 05 12 No 474.23sludges from on-site effluent treatment other than those mentioned in 07 05 11 R13 M Weighed Offsite in Ireland Eras Eco,WO 211-01

Foxhole,Yoghal,Co. Cork,.,Ireland

Within the Country 20 03 07 No 102.85 bulky waste R5 M Weighed Offsite in IrelandGreenstar Recycling Cork,136-2

Sarsfieldcourt,Glanmire ,Cork,.,Ireland

To Other Countries 06 01 02 Yes 5.093 hydrochloric acid D10 M Weighed AbroadIndaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

AVG,IB2234,Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

To Other Countries 06 01 05 Yes 0.231 nitric acid and nitrous acid D10 M Weighed AbroadIndaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

AVG,IB2234,Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

To Other Countries 06 01 06 Yes 0.378 other acids D10 M Weighed AbroadIndaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

AVG,IB2234,Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

To Other Countries 06 02 05 Yes 2.253 other bases D10 M Weighed AbroadIndaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

Indaver NV,MLAVI/9800000485,Polderlietweg,B-2030,Antwerp,.,Belgium

Polderlietweg,B-2030,Antwerp,.,Belgium

To Other Countries 07 05 01 Yes 55.54 aqueous washing liquids and mother liquors D10 M Weighed AbroadIndaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

AVG,IB2234,Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

Method Used

| PRTR# : P0004 | Facility Name : Smithkline Beecham (Cork) Limited | Filename : P0004_2010.xlsm | Return Year : 2010 |

Page 100: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

Sheet : Treatment Transfers of Waste AER Returns Workbook 15/3/2011 9:45

Quantity (Tonnes per

Year)

Haz Waste : Name and Licence/Permit No of Next

Destination Facility Non Haz Waste: Name and Licence/Permit No of

Recover/Disposer

Haz Waste : Address of Next Destination Facility

Non Haz Waste: Address of Recover/Disposer

Name and License / Permit No. and Address of Final Recoverer /

Disposer (HAZARDOUS WASTE ONLY)

Actual Address of Final Destination i.e. Final Recovery / Disposal Site (HAZARDOUS WASTE ONLY)

Transfer DestinationEuropean Waste

Code Hazardous Quantity T/Year Description of Waste

Waste Treatment Operation M/C/E Method Used

Location of Treatment Name and Licence / Permit No. of Recoverer / Disposer / Broker Address of Recoverer / Disposer / Broker Name and Address of Final Destination i.e. Final Recovery / Disposal Site (HAZARDOUS WASTE ONLY) Licence / Permit No. of Final Destination i.e. Final Recovery / Disposal Site (HAZARDOUS WASTE ONLY)

Method Used

To Other Countries 07 05 01 Yes 43.448 aqueous washing liquids and mother liquors D10 M Weighed AbroadIndaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

Indaver NV,MLAVI/9800000485,Polderlietweg,B-2030,Antwerp,.,Belgium

Polderlietweg,B-2030,Antwerp,.,Belgium

To Other Countries 07 05 03 Yes 223.841organic halogenated solvents, washing liquids and mother liquors D10 M Weighed Abroad

Indaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

AVG,IB2234,Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

To Other Countries 07 05 03 Yes 217.492organic halogenated solvents, washing liquids and mother liquors D10 M Weighed Abroad

Indaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

Indaver NV,MLAVI/9800000485,Polderlietweg,B-2030,Antwerp,.,Belgium

Polderlietweg,B-2030,Antwerp,.,Belgium

To Other Countries 07 05 04 Yes 4.544other organic solvents, washing liquids and mother liquors D10 M Weighed Abroad

Indaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

AVG,IB2234,Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

To Other Countries 07 05 04 Yes 53.424other organic solvents, washing liquids and mother liquors D10 M Weighed Abroad

Indaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

AVG,IB2234,Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

Within the Country 07 05 04 Yes 39.9other organic solvents, washing liquids and mother liquors D13 M Weighed Offsite in Ireland

Indaver Ireland,CK WMC 65/01

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

Indaver Ireland,CK WMC 65/01,Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

To Other Countries 07 05 04 Yes 580.18other organic solvents, washing liquids and mother liquors R2 M Weighed Abroad

Indaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

SRM,BV4665IG,Hayhole Rd,North Shields,.,NE29 6DY,United Kingdom

Hayhole Rd,North Shields,.,NE29 6DY,United Kingdom

To Other Countries 07 05 04 Yes 9.327other organic solvents, washing liquids and mother liquors D10 M Weighed Abroad

Indaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

SRM,BL73021D,Middleton Rd,Morecambe,Lancashire,LA3 3JW,United Kingdom

Middleton Rd,Morecambe,Lancashire,LA3 3JW,United Kingdom

To Other Countries 07 05 04 Yes 110.205other organic solvents, washing liquids and mother liquors D10 M Weighed Abroad

Indaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

Indaver NV,MLAVI/9800000485,Polderlietweg,B-2030,Antwerp,.,Belgium

Polderlietweg,B-2030,Antwerp,.,Belgium

To Other Countries 07 05 13 Yes 0.194solid wastes containing dangerous substances D10 M Weighed Abroad

Indaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

AVG,IB2234,Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

To Other Countries 07 05 13 Yes 109.17solid wastes containing dangerous substances D10 M Weighed Abroad

Indaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

Indaver NV,MLAVI/9800000485,Polderlietweg,B-2030,Antwerp,.,Belgium

Polderlietweg,B-2030,Antwerp,.,Belgium

To Other Countries 13 01 13 Yes 2.416 other hydraulic oils D10 M Weighed AbroadIndaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

Indaver NV,MLAVI/9800000485,Polderlietweg,B-2030,Antwerp,.,Belgium

Polderlietweg,B-2030,Antwerp,.,Belgium

To Other Countries 13 01 13 Yes 0.95 other hydraulic oils D10 M Weighed AbroadIndaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

AVG,IB2234,Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

To Other Countries 13 07 01 Yes 2.336 fuel oil and diesel D10 M Weighed AbroadIndaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

Indaver NV,MLAVI/9800000485,Polderlietweg,B-2030,Antwerp,.,Belgium

Polderlietweg,B-2030,Antwerp,.,Belgium

To Other Countries 15 01 10 Yes 0.094packaging containing residues of or contaminated by dangerous substances D10 M Weighed Abroad

Indaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

AVG,IB2234,Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

To Other Countries 15 01 10 Yes 20.137packaging containing residues of or contaminated by dangerous substances D10 M Weighed Abroad

Indaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

Indaver NV,MLAVI/9800000485,Polderlietweg,B-2030,Antwerp,.,Belgium

Polderlietweg,B-2030,Antwerp,.,Belgium

| PRTR# : P0004 | Facility Name : Smithkline Beecham (Cork) Limited | Filename : P0004_2010.xlsm | Return Year : 2010 |

Page 101: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

Sheet : Treatment Transfers of Waste AER Returns Workbook 15/3/2011 9:45

Quantity (Tonnes per

Year)

Haz Waste : Name and Licence/Permit No of Next

Destination Facility Non Haz Waste: Name and Licence/Permit No of

Recover/Disposer

Haz Waste : Address of Next Destination Facility

Non Haz Waste: Address of Recover/Disposer

Name and License / Permit No. and Address of Final Recoverer /

Disposer (HAZARDOUS WASTE ONLY)

Actual Address of Final Destination i.e. Final Recovery / Disposal Site (HAZARDOUS WASTE ONLY)

Transfer DestinationEuropean Waste

Code Hazardous Quantity T/Year Description of Waste

Waste Treatment Operation M/C/E Method Used

Location of Treatment Name and Licence / Permit No. of Recoverer / Disposer / Broker Address of Recoverer / Disposer / Broker Name and Address of Final Destination i.e. Final Recovery / Disposal Site (HAZARDOUS WASTE ONLY) Licence / Permit No. of Final Destination i.e. Final Recovery / Disposal Site (HAZARDOUS WASTE ONLY)

Method Used

Within the Country 15 01 10 Yes 36.716packaging containing residues of or contaminated by dangerous substances R4 M Weighed Offsite in Ireland

Indaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

Rilta,WO192-1,Block 402,Greenogue Business Park ,Rathcoole,Co. Dublin,Ireland

Block 402,Greenogue Business Park ,Rathcoole,Co. Dublin,Ireland

To Other Countries 15 02 02 Yes 0.025

absorbents, filter materials (including oil filters not otherwise specified), wiping cloths, protective clothing contaminated by dangerous substances D10 M Weighed Abroad

Indaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

AVG,IB2234,Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

To Other Countries 15 02 02 Yes 4.183

absorbents, filter materials (including oil filters not otherwise specified), wiping cloths, protective clothing contaminated by dangerous substances D10 M Weighed Abroad

Indaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

AVG,IB2234,Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

To Other Countries 16 03 05 Yes 3.161organic wastes containing dangerous substances D10 M Weighed Abroad

Indaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

AVG,IB2234,Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

To Other Countries 16 03 05 Yes 0.972organic wastes containing dangerous substances D10 M Weighed Abroad

Indaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

Indaver NV,MLAVI/9800000485,Polderlietweg,B-2030,Antwerp,.,Belgium

Polderlietweg,B-2030,Antwerp,.,Belgium

To Other Countries 16 05 06 Yes 0.939

laboratory chemicals, consisting of or containing dangerous substances, including mixtures of laboratory chemicals D10 M Weighed Abroad

Indaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

AVG,IB2234,Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

To Other Countries 16 05 06 Yes 0.363

laboratory chemicals, consisting of or containing dangerous substances, including mixtures of laboratory chemicals D10 M Weighed Abroad

Indaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

Indaver NV,MLAVI/9800000485,Polderlietweg,B-2030,Antwerp,.,Belgium

Polderlietweg,B-2030,Antwerp,.,Belgium

To Other Countries 16 05 07 Yes 0.006discarded inorganic chemicals consisting of or containing dangerous substances D10 M Weighed Abroad

Indaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

AVG,IB2234,Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

To Other Countries 16 05 07 Yes 0.143discarded inorganic chemicals consisting of or containing dangerous substances D10 M Weighed Abroad

Indaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

Indaver NV,MLAVI/9800000485,Polderlietweg,B-2030,Antwerp,.,Belgium

Polderlietweg,B-2030,Antwerp,.,Belgium

To Other Countries 16 05 08 Yes 0.545discarded organic chemicals consisting of or containing dangerous substances D10 M Weighed Abroad

Indaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

AVG,IB2234,Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

To Other Countries 16 05 08 Yes 6.917discarded organic chemicals consisting of or containing dangerous substances D10 M Weighed Abroad

Indaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

Indaver NV,MLAVI/9800000485,Polderlietweg,B-2030,Antwerp,.,Belgium

Polderlietweg,B-2030,Antwerp,.,Belgium

To Other Countries 16 08 07 Yes 11.9spent catalysts contaminated with dangerous substances R8 M Weighed Abroad

Indaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

Johnson Matthey Plc.,253/93,33 Jeffrey's Rd,Enfield ,Middlesex,EN3 7PW ,United Kingdom

33 Jeffrey's Rd,Enfield ,Middlesex,EN3 7PW ,United Kingdom

To Other Countries 16 09 03 Yes 0.006 peroxides, for example hydrogen peroxide D10 M Weighed AbroadIndaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

AVG,IB2234,Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

Abfall-Verwertungs,Gesellschaft,Hamburg,.,Germany

To Other Countries 16 10 01 Yes 6.312aqueous liquid wastes containing dangerous substances D10 M Weighed Abroad

Indaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

Indaver NV,MLAVI/9800000485,Polderlietweg,B-2030,Antwerp,.,Belgium

Polderlietweg,B-2030,Antwerp,.,Belgium

To Other Countries 16 11 05 Yes 1.021

linings and refractories from non-metallurgical processes containing dangerous substances D9 M Weighed Abroad

Indaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

Indaver NV,MLAVI/9800000485,Polderlietweg,B-2030,Antwerp,.,Belgium

Polderlietweg,B-2030,Antwerp,.,Belgium

To Other Countries 17 04 09 Yes 1.978metal waste contaminated with dangerous substances D10 M Weighed Abroad

Indaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

Indaver NV,MLAVI/9800000485,Polderlietweg,B-2030,Antwerp,.,Belgium

Polderlietweg,B-2030,Antwerp,.,Belgium

| PRTR# : P0004 | Facility Name : Smithkline Beecham (Cork) Limited | Filename : P0004_2010.xlsm | Return Year : 2010 |

Page 102: GLAXOSMITHKLINE (CORK) LTD. IPPC LICENCE REGISTER NO. … · GSK Cork Annual Environmental Report 2010 IPPC Licence Reg. No. P0004-03 Page 4 EXECUTIVE SUMMARY In the past year, GlaxoSmithKline

Sheet : Treatment Transfers of Waste AER Returns Workbook 15/3/2011 9:45

Quantity (Tonnes per

Year)

Haz Waste : Name and Licence/Permit No of Next

Destination Facility Non Haz Waste: Name and Licence/Permit No of

Recover/Disposer

Haz Waste : Address of Next Destination Facility

Non Haz Waste: Address of Recover/Disposer

Name and License / Permit No. and Address of Final Recoverer /

Disposer (HAZARDOUS WASTE ONLY)

Actual Address of Final Destination i.e. Final Recovery / Disposal Site (HAZARDOUS WASTE ONLY)

Transfer DestinationEuropean Waste

Code Hazardous Quantity T/Year Description of Waste

Waste Treatment Operation M/C/E Method Used

Location of Treatment Name and Licence / Permit No. of Recoverer / Disposer / Broker Address of Recoverer / Disposer / Broker Name and Address of Final Destination i.e. Final Recovery / Disposal Site (HAZARDOUS WASTE ONLY) Licence / Permit No. of Final Destination i.e. Final Recovery / Disposal Site (HAZARDOUS WASTE ONLY)

Method Used

To Other Countries 17 09 03 Yes 16.068

other construction and demolition wastes (including mixed wastes) containing dangerous substances D10 M Weighed Abroad

Indaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

Indaver NV,MLAVI/9800000485,Polderlietweg,B-2030,Antwerp,.,Belgium

Polderlietweg,B-2030,Antwerp,.,Belgium

To Other Countries 19 01 15 Yes 0.362 boiler dust containing dangerous substances D9 M Weighed AbroadIndaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

Indaver NV,MLAVI/9800000485,Polderlietweg,B-2030,Antwerp,.,Belgium

Polderlietweg,B-2030,Antwerp,.,Belgium

Within the Country 20 01 21 Yes 0.38fluorescent tubes and other mercury-containing waste R4 M Weighed Offsite in Ireland

Indaver Ireland Ltd.,CK WMC 139/03

Tolka Quay Rd.,Dublin Port,Dublin 1,.,Ireland

Irish Lamp Recycling,WFP-KE-0348-01,Blackpark,Kilkenny Rd.,Athy,Co. Kildare,Ireland

Blackpark,Kilkenny Rd.,Athy,Co. Kildare,Ireland

Within the Country 07 05 03 Yes 93.0organic halogenated solvents, washing liquids and mother liquors D10 M Weighed Onsite in Ireland

GlaxoSmithKline,IPPC P0004-03

Currabinny,Ringaskiddy,Cork,.,Ireland

GlaxoSmithKline,IPPC P0004-03,Currabinny,Ringaskiddy,Cork,.,Ireland

Currabinny,Ringaskiddy,Cork,.,Ireland

Within the Country 07 05 04 Yes 2718.0other organic solvents, washing liquids and mother liquors D10 M Weighed Onsite in Ireland

GlaxoSmithKline,IPPC P0004-03

Currabinny,Ringaskiddy,Cork,.,Ireland

GlaxoSmithKline,IPPC P0004-03,Currabinny,Ringaskiddy,Cork,.,Ireland

Currabinny,Ringaskiddy,Cork,.,Ireland

Within the Country 07 05 03 Yes 93.0organic halogenated solvents, washing liquids and mother liquors R1 M Weighed Onsite in Ireland

GlaxoSmithKline,IPPC P0004-03

Currabinny,Ringaskiddy,Cork,.,Ireland

GlaxoSmithKline,IPPC P0004-03,Currabinny,Ringaskiddy,Cork,.,Ireland

Currabinny,Ringaskiddy,Cork,.,Ireland

Within the Country 07 05 04 Yes 1453.0other organic solvents, washing liquids and mother liquors R1 M Weighed Onsite in Ireland

GlaxoSmithKline,IPPC P0004-03

Currabinny,Ringaskiddy,Cork,.,Ireland

GlaxoSmithKline,IPPC P0004-03,Currabinny,Ringaskiddy,Cork,.,Ireland

Currabinny,Ringaskiddy,Cork,.,Ireland

Within the Country 07 05 04 Yes 660.2other organic solvents, washing liquids and mother liquors R2 M Weighed Onsite in Ireland

GlaxoSmithKline,IPPC P0004-03

Currabinny,Ringaskiddy,Cork,.,Ireland

GlaxoSmithKline,IPPC P0004-03,Currabinny,Ringaskiddy,Cork,.,Ireland

Currabinny,Ringaskiddy,Cork,.,Ireland

* Select a row by double-clicking the Description of Waste then click the delete button

Link to previous years waste dataLink to previous years waste summary data & percentage change

| PRTR# : P0004 | Facility Name : Smithkline Beecham (Cork) Limited | Filename : P0004_2010.xlsm | Return Year : 2010 |